NO323684B1 - Process for Preparation of Perbenzylated 1-O-Glycosides - Google Patents
Process for Preparation of Perbenzylated 1-O-Glycosides Download PDFInfo
- Publication number
- NO323684B1 NO323684B1 NO20024290A NO20024290A NO323684B1 NO 323684 B1 NO323684 B1 NO 323684B1 NO 20024290 A NO20024290 A NO 20024290A NO 20024290 A NO20024290 A NO 20024290A NO 323684 B1 NO323684 B1 NO 323684B1
- Authority
- NO
- Norway
- Prior art keywords
- residue
- mmol
- perbenzylated
- general formula
- sugar
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 9
- 150000002772 monosaccharides Chemical class 0.000 claims abstract description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 138
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 54
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 239000002904 solvent Substances 0.000 claims description 39
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 32
- 239000007787 solid Substances 0.000 claims description 25
- -1 phenylene- Chemical class 0.000 claims description 21
- 235000000346 sugar Nutrition 0.000 claims description 19
- 125000006239 protecting group Chemical group 0.000 claims description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
- 238000005804 alkylation reaction Methods 0.000 claims description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 6
- 239000007795 chemical reaction product Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 5
- 230000002152 alkylating effect Effects 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 4
- 239000003444 phase transfer catalyst Substances 0.000 claims description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 3
- 230000029936 alkylation Effects 0.000 claims description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000003983 crown ethers Chemical class 0.000 claims description 2
- 150000004714 phosphonium salts Chemical class 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000007858 starting material Substances 0.000 abstract description 4
- 229930182470 glycoside Natural products 0.000 abstract description 3
- 150000002338 glycosides Chemical class 0.000 abstract description 3
- 150000002430 hydrocarbons Chemical class 0.000 abstract description 3
- CZMRCDWAGMRECN-UHFFFAOYSA-N 2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 103
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 87
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 85
- 239000012074 organic phase Substances 0.000 description 55
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 52
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 41
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 36
- 238000003756 stirring Methods 0.000 description 36
- 239000008346 aqueous phase Substances 0.000 description 33
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 30
- 235000011121 sodium hydroxide Nutrition 0.000 description 29
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 26
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- 239000003480 eluent Substances 0.000 description 20
- 239000000741 silica gel Substances 0.000 description 20
- 229910002027 silica gel Inorganic materials 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 17
- 238000010992 reflux Methods 0.000 description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 13
- 235000019341 magnesium sulphate Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 10
- 238000000921 elemental analysis Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 8
- OGOMAWHSXRDAKZ-HSDAUYOJSA-N (3s,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol Chemical compound C([C@H]1OC([C@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)O)OCC1=CC=CC=C1 OGOMAWHSXRDAKZ-HSDAUYOJSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 6
- 229960003082 galactose Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 description 4
- JVZRADHKCKKVMW-WZMOCLIOSA-N 2-[(3s,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]oxyacetic acid Chemical compound C([C@H]1OC([C@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OCC(=O)O)OCC1=CC=CC=C1 JVZRADHKCKKVMW-WZMOCLIOSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000005858 glycosidation reaction Methods 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- OGOMAWHSXRDAKZ-BKJHVTENSA-N (3r,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol Chemical compound C([C@H]1OC([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)O)OCC1=CC=CC=C1 OGOMAWHSXRDAKZ-BKJHVTENSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- OGOMAWHSXRDAKZ-BJPULKCASA-N (3r,4s,5s,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol Chemical compound C([C@H]1OC([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)O)OCC1=CC=CC=C1 OGOMAWHSXRDAKZ-BJPULKCASA-N 0.000 description 2
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- JVZRADHKCKKVMW-QJOIIPOXSA-N 2-[(3r,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]oxyacetic acid Chemical compound C([C@H]1OC([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OCC(=O)O)OCC1=CC=CC=C1 JVZRADHKCKKVMW-QJOIIPOXSA-N 0.000 description 2
- RTKMFQOHBDVEBC-UHFFFAOYSA-N 3-bromo-3-buten-1-ol Chemical compound OCCC(Br)=C RTKMFQOHBDVEBC-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000007171 acid catalysis Methods 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 150000008266 deoxy sugars Chemical class 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZANNOFHADGWOLI-UHFFFAOYSA-N ethyl 2-hydroxyacetate Chemical compound CCOC(=O)CO ZANNOFHADGWOLI-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 229940075610 mercuric cyanide Drugs 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 229910001958 silver carbonate Inorganic materials 0.000 description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KUYMVWXKHQSIAS-UHFFFAOYSA-N tert-butyl 2-chloroacetate Chemical compound CC(C)(C)OC(=O)CCl KUYMVWXKHQSIAS-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 150000008648 triflates Chemical class 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- HOVAGTYPODGVJG-TVPFVARWSA-N (2r,3r,4s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-TVPFVARWSA-N 0.000 description 1
- OUHUDRYCYOSXDI-KMKAFXEASA-N (2r,3s,4r,5r)-5-hydroxy-2,3,4,6-tetrakis(phenylmethoxy)hexanal Chemical compound C([C@@H](O)[C@@H](OCC=1C=CC=CC=1)[C@H](OCC=1C=CC=CC=1)[C@@H](OCC=1C=CC=CC=1)C=O)OCC1=CC=CC=C1 OUHUDRYCYOSXDI-KMKAFXEASA-N 0.000 description 1
- HOVAGTYPODGVJG-BWSJPXOBSA-N (2r,3s,4s,5s)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-BWSJPXOBSA-N 0.000 description 1
- OGOMAWHSXRDAKZ-RUOAZZEASA-N (2s,3r,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol Chemical compound C([C@H]1O[C@@H]([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)O)OCC1=CC=CC=C1 OGOMAWHSXRDAKZ-RUOAZZEASA-N 0.000 description 1
- OUHUDRYCYOSXDI-YFRBGRBWSA-N (2s,3s,4r,5r)-5-hydroxy-2,3,4,6-tetrakis(phenylmethoxy)hexanal Chemical compound C([C@@H](O)[C@@H](OCC=1C=CC=CC=1)[C@H](OCC=1C=CC=CC=1)[C@H](OCC=1C=CC=CC=1)C=O)OCC1=CC=CC=C1 OUHUDRYCYOSXDI-YFRBGRBWSA-N 0.000 description 1
- ACJXTJOZMROWDH-GQVFOJIBSA-N (3R,4S,5S,6R)-2-benzyl-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol Chemical compound C(C1=CC=CC=C1)O[C@H]1C(O)(O[C@@H]([C@@H]([C@@H]1OCC1=CC=CC=C1)OCC1=CC=CC=C1)COCC1=CC=CC=C1)CC1=CC=CC=C1 ACJXTJOZMROWDH-GQVFOJIBSA-N 0.000 description 1
- NAQUAXSCBJPECG-NITSXXPLSA-N (3r,4r,5r)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-ol Chemical compound C([C@H]1OC([C@@H]([C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)O)OCC1=CC=CC=C1 NAQUAXSCBJPECG-NITSXXPLSA-N 0.000 description 1
- VQFKFAKEUMHBLV-BYSUZVQFSA-N 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)[C@H](O)CCCCCCCCCCCCCC)CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQFKFAKEUMHBLV-BYSUZVQFSA-N 0.000 description 1
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 1
- JVZRADHKCKKVMW-SCSBQZQXSA-N 2-[(3r,4s,5s,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]oxyacetic acid Chemical compound C([C@H]1OC([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OCC(=O)O)OCC1=CC=CC=C1 JVZRADHKCKKVMW-SCSBQZQXSA-N 0.000 description 1
- LTGMAKPPJMWNSN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[tert-butyl(dimethyl)silyl]oxyethylamino]ethylamino]ethylamino]ethylamino]ethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCCNCCNCCNCCNCCO[Si](C)(C)C(C)(C)C)C=C1 LTGMAKPPJMWNSN-UHFFFAOYSA-N 0.000 description 1
- BSULWPSUVMOMAN-UHFFFAOYSA-N 2-azidoethanol Chemical compound OCCN=[N+]=[N-] BSULWPSUVMOMAN-UHFFFAOYSA-N 0.000 description 1
- CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
- QWYTUBPAXJYCTH-UHFFFAOYSA-N 2-trimethylsilylethyl carbamate Chemical class C[Si](C)(C)CCOC(N)=O QWYTUBPAXJYCTH-UHFFFAOYSA-N 0.000 description 1
- GHEBZUIJDOSATC-HRKBRENZSA-N 3-[(3r,4s,5s,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]oxypropan-1-amine Chemical compound C([C@H]1OC([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OCCCN)OCC1=CC=CC=C1 GHEBZUIJDOSATC-HRKBRENZSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- USRQKORYLZCCNS-CAIHAHRASA-N 6-[(3r,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]oxyhexan-1-ol Chemical compound C([C@H]1OC([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OCCCCCCO)OCC1=CC=CC=C1 USRQKORYLZCCNS-CAIHAHRASA-N 0.000 description 1
- HHGMWYZQBBZOER-QKMXTBNJSA-N 6-[(3s,4s,5r,6r)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]oxyhexan-1-amine Chemical compound C([C@H]1OC([C@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)OCCCCCCN)OCC1=CC=CC=C1 HHGMWYZQBBZOER-QKMXTBNJSA-N 0.000 description 1
- PBKXRKYUUXKNSL-UHFFFAOYSA-N 6-bromohexoxy-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCCCCCCBr PBKXRKYUUXKNSL-UHFFFAOYSA-N 0.000 description 1
- ZZOKVYOCRSMTSS-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl carbamate Chemical compound C1=CC=C2C(COC(=O)N)C3=CC=CC=C3C2=C1 ZZOKVYOCRSMTSS-UHFFFAOYSA-N 0.000 description 1
- 102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- WXYNLXPSTFTJJC-HSDAUYOJSA-N C([C@H]1OC([C@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)Br)OCC1=CC=CC=C1 Chemical compound C([C@H]1OC([C@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1OCC=1C=CC=CC=1)OCC=1C=CC=CC=1)Br)OCC1=CC=CC=C1 WXYNLXPSTFTJJC-HSDAUYOJSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000006994 Koenigs-Knorr glycosidation reaction Methods 0.000 description 1
- UDCDOJQOXWCCSD-UHFFFAOYSA-N N,N-dimethyl-N'-p-tolylsulfamide Chemical compound CN(C)S(=O)(=O)NC1=CC=C(C)C=C1 UDCDOJQOXWCCSD-UHFFFAOYSA-N 0.000 description 1
- 238000010934 O-alkylation reaction Methods 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 230000010799 Receptor Interactions Effects 0.000 description 1
- 229910003691 SiBr Inorganic materials 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 108010006523 asialoglycoprotein receptor Proteins 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 1
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical class C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- TXVLFCLSVCYBIV-UHFFFAOYSA-M dimethyl(methylsulfanyl)sulfanium;trifluoromethanesulfonate Chemical compound CS[S+](C)C.[O-]S(=O)(=O)C(F)(F)F TXVLFCLSVCYBIV-UHFFFAOYSA-M 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- ZFAMQJATRWOMHH-UHFFFAOYSA-N ethyl 3-bromo-2-phenylpropanoate Chemical compound CCOC(=O)C(CBr)C1=CC=CC=C1 ZFAMQJATRWOMHH-UHFFFAOYSA-N 0.000 description 1
- ALPFIWHKOHBYEF-UHFFFAOYSA-N ethyl 4-(3-methylsulfonyloxypropyl)benzoate Chemical compound CCOC(=O)C1=CC=C(CCCOS(C)(=O)=O)C=C1 ALPFIWHKOHBYEF-UHFFFAOYSA-N 0.000 description 1
- DXBULVYHTICWKT-UHFFFAOYSA-N ethyl 6-bromohexanoate Chemical compound CCOC(=O)CCCCCBr DXBULVYHTICWKT-UHFFFAOYSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002256 galaktoses Chemical class 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- DTBGILDKBIBTGE-UHFFFAOYSA-N n-(1-hydroxyethyl)formamide Chemical compound CC(O)NC=O DTBGILDKBIBTGE-UHFFFAOYSA-N 0.000 description 1
- XRRCVJUSXHXUHS-UHFFFAOYSA-N n-(4-bromobutyl)-2-trimethylsilylethanesulfonamide Chemical compound C[Si](C)(C)CCS(=O)(=O)NCCCCBr XRRCVJUSXHXUHS-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- KUOSNTKAZFIQSS-UHFFFAOYSA-N tert-butyl 6-(4-methylphenyl)sulfonyloxyhexanoate Chemical compound CC1=CC=C(S(=O)(=O)OCCCCCC(=O)OC(C)(C)C)C=C1 KUOSNTKAZFIQSS-UHFFFAOYSA-N 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- CITILBVTAYEWKR-UHFFFAOYSA-L zinc trifluoromethanesulfonate Chemical compound [Zn+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F CITILBVTAYEWKR-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
Beskrivelse Description
Oppfinnelsen angår en ny fremgangsmåte for fremstilling av perbenzylerte l-O-glykosider med den generelle formel I som er nærmere kjennetegnet i patentkravene. Fremgangsmåten ifølge oppfinnelsen starter med prisgunstige utgangsmaterialer, leverer gode utbytter og tillater fremstilling av perbenzylerte sakkarider med 1-0-funksjonaliserte sidekjeder i stor målestokk. The invention relates to a new process for the production of perbenzylated 1-O-glycosides with the general formula I which is characterized in more detail in the patent claims. The process according to the invention starts with inexpensive starting materials, delivers good yields and allows the production of perbenzylated saccharides with 1-0-functionalized side chains on a large scale.
Perbenzylerte sakkaridderivater er verdifulle mellomprodukter innen syntesekjemien. Fremfor alt anvender den farma-søytiske kjemi slike byggestener meget hyppig da mange høy-potente og selektive farmaka bærer sukkerrester. Således er f.eks. i Journal of Drug Targeting 1995, vol. 3, s. 111-127, anvendelser av den såkalte "Glycotargetings" beskrevet. Såkalte "multi-antennary sugar chains" er beskrevet i Chemistry Letters 1998, s. 823. Ved hjelp av "clustering" av sukkerenheter blir karbohydratreseptorvekselvirkningen ved celle-celle-inter-aksjonen vesentlig forbedret. Syntesen av galaktosider med høy affinitet overfor asialoglykoproteinreseptor er blitt publisert i J. Med. Chem. 1995, 38, s. 1538 (se også Int. J. Peptide Protein Res. 43, 1994, s. 477). Her blir derivatiserte galak-toser med funksjonaliserte sidekjeder fremstilt som deretter kan henges på forskjellige andre molekyler. En god oversikt over anvendelsen av sakkarider som basis for glykobiologien er gitt i Acc. Chem. Res. 1995, 321. Også for syntesen av LewisX Mimetika {Tet. Lett. vol. 31, 5503) tjener funksjonaliserte monosakkarider som forhåndstrinn (se også JACS 1996, 118, 6826). Perbenzylated saccharide derivatives are valuable intermediates in synthetic chemistry. Above all, pharmaceutical chemistry uses such building blocks very frequently, as many highly potent and selective pharmaceuticals contain sugar residues. Thus, e.g. in Journal of Drug Targeting 1995, vol. 3, pp. 111-127, applications of the so-called "Glycotargetings" described. So-called "multi-antennary sugar chains" are described in Chemistry Letters 1998, p. 823. By means of "clustering" of sugar units, the carbohydrate receptor interaction during the cell-cell interaction is significantly improved. The synthesis of galactosides with high affinity for the asialoglycoprotein receptor has been published in J. Med. Chem. 1995, 38, p. 1538 (see also Int. J. Peptide Protein Res. 43, 1994, p. 477). Here, derivatized galactoses with functionalized side chains are produced which can then be attached to various other molecules. A good overview of the use of saccharides as a basis for glycobiology is given in Acc. Chem. Res. 1995, 321. Also for the synthesis of LewisX Mimetika {Tet. Easy. Vol. 31, 5503) functionalized monosaccharides serve as precursors (see also JACS 1996, 118, 6826).
Anvendelsen av derivatiserte monosakkarider som mellom-trinn for potensielle farmasøytika er godt redegjort for i Current Medicinal Chemistry, 1995, 1, 392. Perbenzylerte-1-OH-sukkerderivater (galaktose, glukose) blir også anvendt ved syntesen av hjerteaktive glykosider (digitoksinkonjugater). l-O-glykosider ingen finner her sted via trikloracetimidat og BF3-katalyse <J. Med. Chem. 1986, 29, s. 1945). For fremstilling av immobiliserte sukkerligander (f.eks. for tilkobling til HSA) The use of derivatized monosaccharides as intermediates for potential pharmaceuticals is well explained in Current Medicinal Chemistry, 1995, 1, 392. Perbenzylated 1-OH sugar derivatives (galactose, glucose) are also used in the synthesis of cardiac active glycosides (digitoxin conjugates). l-O-glycosides none take place here via trichloroacetimidate and BF3 catalysis <J. With. Chem. 1986, 29, p. 1945). For the preparation of immobilized sugar ligands (e.g. for connection to HSA)
blir funksjonaliserte, beskyttede monosakkarider anvendt functionalized, protected monosaccharides are used
{Chemical Society Reviews 1995, s. 413). (Chemical Society Reviews 1995, p. 413).
En gruppe av synteser har til mål via en l-O-glyko-sideringsreaksjon å innføre tilleggsfunksjonalitet i sukker- molekylet. Her er fremfor alt endestående COOH-, amino- eller OH-grupper av interesse da disse kan omsettes videre i påfølg-ende trinn. One group of syntheses aims to introduce additional functionality into the sugar molecule via an 1-O-glycosidation reaction. Above all, terminal COOH, amino or OH groups are of interest here, as these can be converted further in subsequent steps.
Fremstillingen av l-O-glykosider finner i de fleste tilfeller sted i henhold til klassiske metoder, så som f.eks. i henhold til den av Koenigs-Knorr, Helferich, eller den av R. R. Schmidt beskrevne trikloracetimidatmetode [W. Koenigs og E. Knorr, Ber. dtsch. chem. Ges. 34 (1901) 957; B. Helferich og J. Goendeler, Ber. dtsch. Chem. Ges. 73 (1940) 532; B. Helferich, W. Piel og F. Eckstein, Chem. Ber. 94 (1961), 491; B. Helferich og W..M. Muller, Chem. Ber. 1970, 103, 3350; G. Wulff, G. Rohle og W. Kriiger, Ang. Chem. Internat. Edn., 1970, 9, 455; J.M. Berry og G.G.S. Duthon, Canad. J. Chem. 1972, 50, 1424; R.R. Schmidt, Angew. Chem. 1986, 98, 213]. The production of l-O-glycosides takes place in most cases according to classical methods, such as e.g. according to the method of Koenigs-Knorr, Helferich, or the trichloroacetimidate method described by R.R. Schmidt [W. Koenigs and E. Knorr, Ber. dtsch. chem. Ges. 34 (1901) 957; B. Helferich and J. Goendeler, Ber. dtsch. Chem. Ges. 73 (1940) 532; B. Helferich, W. Piel and F. Eckstein, Chem. Pray. 94 (1961), 491; B. Helferich and W..M. Muller, Chem. Pray. 1970, 103, 3350; G. Wulff, G. Rohle and W. Kriiger, Ang. Chem. Boarding school. Edn., 1970, 9, 455; J.M. Berry and G.G.S. Duthon, Canada. J. Chem. 1972, 50, 1424; R. R. Schmidt, Angew. Chem. 1986, 98, 213].
Alle disse metoder har det til felles at 1-hydroksyl-gruppen overføres til en reaktiv form som til slutt tjener som avgangsgruppe. Den egentlige omsetning med en alkohol til 1-0-glykosid finner sted under Lewis-syrekatålyse (delvis i støkio-metrisk mengde). For slike omsetninger finnes tallrike eksempler i litteraturen. All these methods have in common that the 1-hydroxyl group is transferred to a reactive form which ultimately serves as a leaving group. The actual reaction with an alcohol to 1-0-glycoside takes place under Lewis acid catalysis (partially in stoichiometric amount). There are numerous examples of such transactions in the literature.
Således er ved fremstillingen av immunostimulansen KRN-7000 (Kirin Brewery) kondensasjonen av tetra-O-benzyl- -D-galak-topyranosylbromid med en primær alkohol hvis hydroksylgruppe sitter ved enden av en di-hydroksyamido-C-kjede (i DMF/toluen under Lewis-syrekatalyse) et sentralt trinn (Drug of the Future 1997, 22(2), s. 185). I det japanske patent JP 95-51764 er omsetningen av l-0-acetyl-2,3,4-tri-O-benzyl-L-fukopyranose med polyoksyetylen-30-fytosterol (BPS-30, NIKKO Chem., Japan) under trimetylsilylbromid/sinktriflatkatalyse blitt beskrevet. I Bull. Chem. Soc. 1982, 55(4), s. 1092-6 er 1-O-glykosideringer av perbenzylsukkere under titantetrakloridkatalyse i diklormetan beskrevet. Thus, in the preparation of the immunostimulant KRN-7000 (Kirin Brewery) the condensation of tetra-O-benzyl--D-galac-topyranosyl bromide with a primary alcohol whose hydroxyl group sits at the end of a di-hydroxyamido-C chain (in DMF/toluene during Lewis acid catalysis) a key step (Drug of the Future 1997, 22(2), p. 185). In the Japanese patent JP 95-51764, the reaction of 1-0-acetyl-2,3,4-tri-O-benzyl-L-fucopyranose with polyoxyethylene-30-phytosterol (BPS-30, NIKKO Chem., Japan) under trimethylsilyl bromide/zinc triflate catalysis has been described. In Bull. Chem. Soc. 1982, 55(4), pp. 1092-6, 1-O-glycosidations of perbenzyl sugars under titanium tetrachloride catalysis in dichloromethane are described.
I Liebigs Ann. Org. Bioorg. Chem.; EN; 9; 1995; 1673-1680, er fremstillingen av 3,4,5-trisbenzyloksy-2-benzyloksy-metyl-6-(2-heksadecyloksyetoksy)-tetrahydropyran beskrevet. Utgående fra 2,3,4,6-tetra-O-benzyl-D-glukopyranose blir l-O-glykosider ingen utført under anvendelse av Bu4NBr, CoBr2, Me3SiBr og molekylsil i metylenklorid utført i løpet av 60 timer. In Liebig's Ann. Org. Bioorg. Chem.; ONE; 9; 1995; 1673-1680, the preparation of 3,4,5-trisbenzyloxy-2-benzyloxy-methyl-6-(2-hexadecyloxyethoxy)-tetrahydropyran is described. Starting from 2,3,4,6-tetra-O-benzyl-D-glucopyranose, 1-O-glycosides are not obtained using Bu 4 NBr, CoBr 2 , Me 3 SiBr and molecular sieve in methylene chloride carried out within 60 hours.
Et tetrabenzylderivat som inneholder en endestående karboksylgruppe som er beskyttet som metylester, er beskrevet i Carbohydr. Res.; EN; 230; 1; 1992; 117. Karboksylgruppen kan deretter frigjøres og omsettes videre. For glykosideringen blir sølvkarbonat i diklormetan anvendt. Anvendelsen av det dyre sølvkarbonat begrenser chargestørrelsen og gjør en økonomisk oppskalering nærmest umulig. Det samme problem gjelder for den påfølgende forbindelse som er blitt beskrevet i Tetrahedron Lett. 30, 44, 1989, s. 6019. Her blir 2,3,4,6-tetra-O-benzyl-D-mannosylbromid i nitrometan omsatt til 1-O-glykosidet med 2-benzyloksyetanol under hjelpende medvirkning av kvikksølvcyanid. Anvendelsen av kvikksølvcyanid i prøveanlegg er problematisk og må frarådes av miljøvernmessige grunner. A tetrabenzyl derivative containing a terminal carboxyl group protected as a methyl ester is described in Carbohydr. Res.; ONE; 230; 1; 1992; 117. The carboxyl group can then be released and reacted further. For the glycosidation, silver carbonate in dichloromethane is used. The use of the expensive silver carbonate limits the charge size and makes an economic scale-up almost impossible. The same problem applies to the subsequent compound which has been described in Tetrahedron Lett. 30, 44, 1989, p. 6019. Here, 2,3,4,6-tetra-O-benzyl-D-mannosyl bromide in nitromethane is converted to the 1-O-glycoside with 2-benzyloxyethanol with the aid of mercuric cyanide. The use of mercuric cyanide in test facilities is problematic and must be discouraged for environmental protection reasons.
Substansbibliotekene for høyproduktivskreening som er beskrevet i nyere tid, anvender meget hyppig sakkarider (Angew. Chemie 1995, 107, 2912). Her er målet at sukkerbyggestener skal foreligge i beskyttet form som bærer en funksjonell gruppe, som f.eks. -COOH eller -NH2, som f.eks. kan bli omsatt i en automat-isert syntese. Byggestenene som finner anvendelse for dette, er blitt beskrevet i Lockhoff, Angew. Chem. 1998, 110(24), s. 3634. Fremfor alt er her 1-O-eddiksyren av perbenzylglukose av betydning. Fremstillingen finner sted i 2 trinn, via trikloracetimidat og omsetning med hydroksyeddiksyreetylester, BF3-katalyse i THF og påfølgende forsåpning med NaOH i MeOH/THF. Det samlede utbytte over 2 trinn utgjør imidlertid bare 59%. The substance libraries for high-throughput screening that have been described in recent times very frequently use saccharides (Angew. Chemie 1995, 107, 2912). Here, the goal is for sugar building blocks to be available in a protected form that carries a functional group, such as e.g. -COOH or -NH2, such as can be implemented in an automated synthesis. The building blocks that find use for this have been described in Lockhoff, Angew. Chem. 1998, 110(24), p. 3634. Above all, the 1-O-acetic acid of perbenzylglucose is important here. The preparation takes place in 2 steps, via trichloroacetimidate and reaction with hydroxyacetic acid ethyl ester, BF3 catalysis in THF and subsequent saponification with NaOH in MeOH/THF. However, the overall yield over 2 stages amounts to only 59%.
1-0-eddiksyreetylesteren som da gjennomløpes forbigå-ende, blir i henhold til EP 882733 erholdt ved omsetning av 2,3,4,6-tetra-O-benzylglukose med hydroksyeddiksyreetylester i nærvær av katalytiske mengder av p-toluensulfonsyre ved koking i benzen ved tilbakeløp, men riktignok uten angivelse av utbyttet. The 1-0-acetic acid ethyl ester which is then passed through transiently is, according to EP 882733, obtained by reacting 2,3,4,6-tetra-O-benzylglucose with hydroxyacetic acid ethyl ester in the presence of catalytic amounts of p-toluenesulfonic acid by boiling in benzene in the event of a return, but admittedly without specifying the dividend.
I den samme publikasjon blir også fremstillingen av et 1-0-(aminoetyl)-glykosid av den perbenzylerte glukose beskrevet. Omsetningen finner sted, igjen utgående fra trikloracetimidatet, ved omsetning med N-formylaminoetanol under BF3-katalyse i THF og påfølgende forsåpning i MeOH/THF. Det samlede utbytte er også her relativt lavt og utgjør 45%. In the same publication, the preparation of a 1-O-(aminoethyl)-glycoside of the perbenzylated glucose is also described. The reaction takes place, again starting from the trichloroacetimidate, by reaction with N-formylaminoethanol under BF3 catalysis in THF and subsequent saponification in MeOH/THF. The overall dividend is also relatively low here and amounts to 45%.
Et 1-0-(aminoetyl)-derivat av perbenzylxylose passeres ifølge Carbohydrate Research 1997, 298, s. 173, som mellompro-dukt. Syntesen er imidlertid meget omstendelig da den starter fra 1-bromperacetatet av xylosen. Den egentlige 1-O-glykosider-ing finner sted via en 1-fenyltioeter som omsettes med 2-azido-etanol under DMTST-katalyse (= dimetyl (metyltio)-sulfonium-triflat) i diklormetan (samlet trinnantall: 7). Det samlede utbytte er med under 40% ikke egnet for en industriell anvendelse. A 1-O-(aminoethyl) derivative of perbenzylxylose is passed according to Carbohydrate Research 1997, 298, p. 173, as an intermediate product. However, the synthesis is very complicated as it starts from the 1-bromoacetate of xylose. The actual 1-O-glycosidation takes place via a 1-phenylthioether which is reacted with 2-azido-ethanol under DMTST catalysis (= dimethyl (methylthio)-sulfonium triflate) in dichloromethane (total number of steps: 7). At less than 40%, the total yield is not suitable for an industrial application.
I oversiktsartikkelen av R.R. Schmidt i Angew. Chem. 1986, 98, s. 213-236, blir direkte omsetninger av 1-OH-perbenzylglukose og -ribose med 2-halogenestere og triflater beskrevet. Som base blir natriumhydrid i THF eller benzen anvendt (Chem. Ber. 1982, 115). Utbyttene ligger mellom 40 og 55%. Også anvendelsen av natriumhydrid i dioksan eller kalium-tert.-butylat i THF (begge ved romtemperatur) er beskrevet for 1-0-alkyleringen med triflater (Angew. Chem. 1986, 98, s. 218) . De vannfrie reaksjonsbetingelser som strengt må overholdes, representerer en stor hindring ved oppskaleringen av slike alkyler-inger. In the review article by R.R. Schmidt in Angew. Chem. 1986, 98, pp. 213-236, direct reactions of 1-OH-perbenzylglucose and -ribose with 2-halogenesters and triflates are described. Sodium hydride in THF or benzene is used as a base (Chem. Ber. 1982, 115). The yields are between 40 and 55%. Also the use of sodium hydride in dioxane or potassium tert.-butylate in THF (both at room temperature) is described for the 1-0-alkylation with triflates (Angew. Chem. 1986, 98, p. 218). The anhydrous reaction conditions, which must be strictly adhered to, represent a major obstacle in scaling up such alkylations.
Alle hittil kjente fremgangsmåter er beheftet med den store ulempe at en oppskalering av prosessen ikke uten videre lar seg virkeliggjøre. Anvendelsen av Lewis-syrer ved l-O-glykosider ingen så vel som av natriumhydrid ved 1-O-alkyleringen krever alltid vannfrie reaksjonsbetingelser hvilket alltid er forbundet med vanskeligheter ved store charger. Også opparbeid-elsen og fjerningen av reaksjonshjelpestoffene (Hg/cyanid/etc.) er et problem i flere tilfeller. All previously known methods are burdened with the major disadvantage that scaling up the process cannot be realized without further ado. The use of Lewis acids in 1-O-glycosides none as well as of sodium hydride in the 1-O-alkylation always requires anhydrous reaction conditions, which is always associated with difficulties with large charges. The processing and removal of the reaction aids (Hg/cyanide/etc.) is also a problem in several cases.
Det var derfor oppfinnelsens oppgave å tilveiebringe en fremgangsmåte ved hjelp av hvilken perbenzylerte sakkarider med 1-0-funksjonalisert sidekjede kunne fremstilles økonomisk og miljøvennlig i større målestokk. It was therefore the task of the invention to provide a method by means of which perbenzylated saccharides with a 1-0-functionalized side chain could be produced economically and environmentally friendly on a larger scale.
Oppfinnelsens oppgave løses ifølge fremgangsmåten som er angitt i patentkravene, ved hjelp av hvilken perbenzylerte 1-O-glykosider med den generelle formel I The task of the invention is solved according to the method stated in the patent claims, by means of which perbenzylated 1-O-glycosides of the general formula I
vil kunne fremstilles. Ifølge oppfinnelsens definisjon betyr sukker<1>i den generelle formel I et i 1-OH-posisjon funksjonalisert monosakkarid, hvorved det her også kan dreie seg om will be able to be produced. According to the invention's definition, sugar<1> in the general formula I means a monosaccharide functionalized in the 1-OH position, whereby it can also refer to
desoksysukker som istedenfor én eller flere OH-grupper inneholder et H-atom. Ifølge en foretrukken utførelsesform av oppfinnelsen betyr sukkeret i den generelle formel I et monosakkarid med 5 eller 6 C-atomer, f.eks. glukose, mannose, galaktose, ribose, arabinose eller xylose eller deres desoksysukker, som f.eks. €-desoksygalaktose (fukose) eller 6-desoksy-mannose (rhamnose). deoxysugars which instead of one or more OH groups contain an H atom. According to a preferred embodiment of the invention, the sugar in the general formula I means a monosaccharide with 5 or 6 C atoms, e.g. glucose, mannose, galactose, ribose, arabinose or xylose or their deoxysugars, such as e.g. €-deoxygalactose (fucose) or 6-deoxy-mannose (rhamnose).
Resten R representerer, benzyl gruppen som i avhengighet av det anvendte monos akkar id eller dets desoksyform er til stede minst dobbelt og ved anvendelse av di-, tri- eller polysakkar-ider er tilsvarende til stede flere ganger. The residue R represents the benzyl group which, depending on the monosaccharide used or its deoxyform, is present at least twice and when using di-, tri- or polysaccharides is correspondingly present several times.
Resten X betyr -0-, -S-, -C00- eller -NH-. Som resultat av fremgangsmåten ifølge oppfinnelsen blir følgelig alkoholer, karboksylsyrer eller aminer med den generelle formel I oppnådd. The residue X means -O-, -S-, -C00- or -NH-. As a result of the method according to the invention, alcohols, carboxylic acids or amines with the general formula I are consequently obtained.
Resten L kan bety en rettkjedet, forgrenet, mettet eller umettet Cj-Cjo-karbonkjede som eventuelt er avbrutt av 1-10 oksygenatomer, 1-3 svovelatomer, 1-2 fenylen-, 1-2 fenylenoksy-, 1-2 fenylendioksygrupper, en tiofen-, pyrimidin- eller pyridinrest og/eller eventuelt er substituert med 1-3 fenyl-,. 1-3 karboksyl-, 1-5 hydroksy-, 1-5 O-Cj-Gj-alkyl-, 1-3 aminogrupper, 1-3 CF3-grupper eller 1-10 fluor a tomer. I henhold til oppfinnelsen er foretrukne rester L hvorved Y betyr tilknytningsstedet til sukkeret, og c er tilknytningsstedet til resten X. En spesielt foretrukken tilknyt-nings formidl er. L er -CHa-gruppen. For fremstilling av de perbenzylerte l-O-glykosider med den generelle formel I blir et perbenzylert 1-0H-sukker med den generelle formel II hvori sukker, R og n har den ovenfor angitte betydning, oppløst i et organisk løsningsmiddel som ikke er blandbart med vann, og omsatt med et alkyleringsreagens med den generelle formel III hvori Nu betyr en nukleofug, L og X har den nevnte betydning, og Bg er en beskyttelsesgruppe, i nærvær av en base og eventuelt en faseoverføringskatalysator. Som nukleofug kan f.eks. restene -Cl, -Br, -J, -OTs, -OMs, -OSOjCFj, -OS02CtF9eller -OS03C8F17være inneholdt i alkyleringsreagenset med den generelle formel III. The residue L can mean a straight-chain, branched, saturated or unsaturated Cj-Cjo carbon chain which is optionally interrupted by 1-10 oxygen atoms, 1-3 sulfur atoms, 1-2 phenylene, 1-2 phenyleneoxy, 1-2 phenylenedioxy groups, a thiophene, pyrimidine or pyridine residue and/or is optionally substituted with 1-3 phenyl-,. 1-3 carboxyl, 1-5 hydroxy, 1-5 O-Cj-Gj-alkyl, 1-3 amino groups, 1-3 CF3 groups or 1-10 fluorine atoms. According to the invention, preferred residues are L whereby Y means the site of attachment to the sugar, and c is the site of attachment to the residue X. A particularly preferred means of attachment is. L is the -CHa group. For the preparation of the perbenzylated 1-O-glycosides of the general formula I, a perbenzylated 1-0H-sugar of the general formula II in which sugar, R and n have the above meaning is dissolved in an organic solvent that is not miscible with water, and reacted with an alkylating reagent of the general formula III in which Nu means a nucleofuge, L and X have the aforementioned meaning, and Bg is a protecting group, in the presence of a base and optionally a phase transfer catalyst. As a nucleofuge, e.g. the residues -Cl, -Br, -J, -OTs, -OMs, -OSOjCFj, -OSO 2 CtF 9 or -OSO 3 C 8 F 17 be contained in the alkylating reagent of the general formula III.
For beskyttelsesgruppen Bg dreier det seg om en vanlig syre- eller amin-, hydroksy- eller tiolbeskyttelsesgruppe alt etter hvorvidt X betyr resten -0-, -C00- eller -NH-. Disse beskyttelsesgrupper kjenner fagmannen godt til (Protective Groups in Organic Syntheses, 2. utg., T.W. Greene og P.G.M. Wuts, John Wiley&Sons, Inc., New York 1991). For the protecting group Bg, it is a common acid or amine, hydroxy or thiol protecting group, depending on whether X means the residue -0-, -C00- or -NH-. These protective groups are well known to the person skilled in the art (Protective Groups in Organic Syntheses, 2nd ed., T.W. Greene and P.G.M. Wuts, John Wiley&Sons, Inc., New York 1991).
Omsetningen ifølge oppfinnelsen kan finne sted ved temperaturer fra 0-50 °C, fortrinnsvis fra 0 °C til romtemperatur. Reaksjonstidene utgjør fra 10 minutter til 24 timer, fortrinnsvis fra 20 minutter til 12 timer. The reaction according to the invention can take place at temperatures from 0-50 °C, preferably from 0 °C to room temperature. The reaction times are from 10 minutes to 24 hours, preferably from 20 minutes to 12 hours.
Basen blir tilsatt enten i fast form, fortrinnsvis finpulverisert, eller som 10-70%-ig, fortrinnsvis 30-50%-ig, vandig oppløsning. NaOH og KOH tjener som foretrukne baser. The base is added either in solid form, preferably finely powdered, or as a 10-70%, preferably 30-50%, aqueous solution. NaOH and KOH serve as preferred bases.
Som organiske løsningsmidler som ikke er blandbare med vann, kan for alkyleringsprosessen ifølge oppfinnelsen f.eks. toluen, benzen, CF3-benzen, heksan, sykloheksan, dietyleter, tetrahydrofuran, diklormetan, MTB eller blandinger derav anvendes. As organic solvents that are not miscible with water, for the alkylation process according to the invention, e.g. toluene, benzene, CF3-benzene, hexane, cyclohexane, diethyl ether, tetrahydrofuran, dichloromethane, MTB or mixtures thereof are used.
Som faseoverføringskatalysatorer for fremgangsmåten ifølge oppfinnelsen tjener de for dette formål kjente kvartære ammonium- eller fosfoniumsalter eller også kroneetere, som f.eks. [15]-krone-5- eller [18]-krone-6. Fortrinnsvis kommer kvartære ammoniumsalter med fire like eller forskjellige hydrokarbongrupper på kationet valgt fra metyl, etyl, propyl, isopropyl, butyl eller isobutyl, på tale. Hydrokarbongruppene på kationet må være tilstrekkelig store til å sikre en god oppløse-lighet av alkyleringsreagenset i det organiske løsningsmiddel. Ifølge oppfinnelsen blir N(butyl)4<+->Cl", N (butyl) 4+-HS04", men også N (metyl) 4*-Cl" fortrinnsvis anvendt. ;Etter at omsetningen har funnet sted, kan opparbeid-elsen av reaksjonsblåndingen finne sted ved isolering av det fremdeles beskyttede sluttprodukt og med påfølgende vanlig avspaltning av beskyttelsesgruppen til sluttproduktet med den generelle formel I. Det foretrekkes imidlertid at fremdeles beskyttet sluttprodukt ikke isoleres, men at løsningsmidlet fjernes, at resten tas opp i et nytt løsningsmiddel som er egnet for avspaltningen av beskyttelsesgruppen og at avspaltningen gjennomføres her. Fremgangsmåten for avspaltning av beskyttelsesgruppen og for regenereringen av syre-, amino-, hydroksy-eller tiolgruppen er godt kjent for fagmannen. ;Dreier det seg f.eks. for beskyttelsesgruppen Bg om en syrebeskyttelsesgruppe som blokkerer karboksygruppens sure proton, altså f.eks. om metyl, etyl, benzyl eller tert.-butyl, blir syren regenerert på vanlig måte ved hjelp av alkalisk hydrolyse. Ved fremgangsmåten ifølge oppfinnelsen blir for dette tilfelle nå resten, etter fjerning av løsningsmidlet fra alkyl-eringsreaksjonen, tatt opp i et nytt løsningsmiddel, f.eks. metanol, etanol, tetrahydrofuran, isopropanol, butanol eller dioksan. En vandig oppløsning av en base blir deretter tilsatt, og den alkaliske hydrolyse blir utført ved temperaturer fra 0-100 °C. ;Som hydroksybeskyttelsesgrupper kommer f,eks. benzyl-, 4-metoksybenzyl-, 4-nitrobenzyl-, trityl-, difenylmetyl-, tri-metylsilyl-, dimetyl-tert.-butylsilyl- eller difenyl-tert.-butylsilylgrupper på tale. ;Hydroksygruppene kan også foreligge f .eks. som THP-eter, ot-alkoksyetyleter, MEM-eter eller også som ester med aromatiske eller alifatiske karboksylsyrer, som f.eks. eddiksyre eller benzosyre. I tilfellet av polyoler kan hydroksygruppene også være beskyttet i form av ketaler med f.eks. aceton, acetaldehyd, sykloheksanon eller benzaldehyd. Hydroksybeskyttelsesgruppene kan i henhold til litteraturmetoder som er kjent for fagmannen, f.eks. ved hydrogenolyse, syrebehandling av eterne og ketalene, alkalibehandling av esterne eller behandling av silylbeskytt-elsesgruppene med fluorid, frigjøres (se f.eks. Protective Groups in Organic Syntheses, 2. utg., T.W. Greene og P.G.M. Wuts, John Wiley & Sons, Inc., New York, 1991) . ;Tiolgruppene kan beskyttes som benzyletere som er spaltbare med natrium i ammoniakk eller kokende etanol (W.J. Patterson, v. du Vigneaud, J. Biol. Chem. 111:393, 1993). S-tert.-butyletere er lett spaltbare med hydrogenfluorid/anisol ved romtemperatur (S. Salzakibona et al., Bull. Chem. Soc. Japn., 40:2164 (1967)]. S-benzyloksykarbonylderivater kan bekvemt spaltes ved hjelp av konsentrert ammoniakkoppløsning ved romtemperatur (A. Berger et al., J. Am. Chem. Soc, 78:4483, 1956). Først ved koke temper at ur blir S-benzyloksykarbonylderivater av trifluoreddiksyre spaltet [L. Zervas et al., J. Am. Chem. Soc, 85:1337 (1963)]. NH2-gruppene kan beskyttes på mange måter og igjen frigjøres. N-trifluoracetylderivatet blir spaltet ved hjelp av kalium- eller natriumkarbonat i vann [H. Newman, J. Org. Chem., 30:287 (1965), M.A. Schwartz et al., J. Am. Chem. Soc, 95 G12 (1973)] eller ganske enkelt ved hjelp av ammoniakkoppløsning [M. Imazama og F. Eckstein, J. Org. Chem., 44:2039 (1979)]. Likeledes er tert.-butyloksykarbonylderivatet lett å spalte. Det er tilstrekkelig med omrøring med trifluoreddiksyre [B.F. Lundt et al., J. Org. Chem., 43:2285 (1978)]. Gruppen av NH2-beskyttelsesgrupper som kan spaltes hydrogenolytisk eller reduserende, er meget stor: N-benzylgruppen lar seg bekvemt spalte med hydrogen/Pd-C [W.H. Hartung og R. Simonoff, Org. Reactions VII, 263 (1953)], hvilket også gjelder for tritylgruppen [L. Zervas et al., J. Am. Chem. Soc, 78:1359 (1956)] og benzyloksykarbonylgruppen [M. Bergmann og L. Zervas, Ber. 65:1192 (1932)]. ;Av silylderivatene blir de lett spaltbare tert.-butyldifenyl-silylforbindelser [L.E. Overman et al., Tetrahedron Lett., 27:4391 (1986)] så vel som 2-(trimetylsilyl)-etylkarbamatene [L. Grehn et al., Angew. Chem. Int. Ed. Engl., 23:296 (1983)] og 2-trimetylsilyletansulfonamidene [R.S. Garigipati og S.M. Weinreb, J. Org. Chem., 53:4134 (1988)] anvendt, hvilke kan spaltes med fluoridioner. 9-fluorenylmetylkarbamat er spesielt lett spalt-bart. Spaltningen finner sted med aminer, så som piperidin, morfolin, 4-dimetylaminopyridin, men også med tetrabutylammoniumfluorid [L.A. Corpino et al., J. Org. Chem., 55:1673 (1990); M. Ueki og M. Amemiya, Tetrahedron Lett., 28:6617 (1987)]. ;Isoleringen av det erholdte sluttprodukt med den generelle formel I (alkohol, tiol, amin eller karboksylsyre) finner likeledes sted -i henhold til vanlige metoder som er godt kjent for fagmannen. Således blir f.eks. i tilfellet med syrebeskytt-elsesgruppen løsningsmidlet avdampet fra hydrolysereaksjonen og resten tatt opp i et aprotisk løsningsmiddel. Ved surgjøring med en vandig syreoppløsning blir pH innstilt på ca. 2-4, og deretter blir den organiske fase fraskilt. Det perbenzylerte 1-0-glykosid kan nå utvinnes ved hjelp av krystallisasjon eller kromatografi. ;Eventuelt kan de erholdte forbindelser med den generelle formel I også overføres til deres salter på vanlig måte. ;Utbyttene av forbindelsene med den generelle formel I, hvilke kan oppnås med fremgangsmåten ifølge oppfinnelsen, er gode. De ligger for kjente forbindelser, for hvilke en sammen-ligning med teknikkens stand er mulig, over utbyttene i henhold til teknikkens stand. Således blir f.eks. for 1-0-eddiksyre av perbenzylert glukose et samlet utbytte på 59% beskrevet i Angew. Chem. 1998, 110 (24), s. 3634, med den der nevnte fremgangsmåte, mens ifølge oppfinnelsen utbyttet for denne forbindelse over 2 trinn utgjør 82% (smlgn. eksempel 7 i den foreliggende patent-søknad) . Også fremstillingen av forbindelsen ifølge eksempel 12 i den foreliggende patentsøknad blir beskrevet i denne publikasjon. Mens utbyttet av denne forbindelse utgjør 78% ifølge oppfinnelsen over 2 trinn, blir med den fremgangsmåte som er beskrevet i publikasjonen, bare 45% oppnådd. ;Foruten de høye utbytter byr fremgangsmåten ifølge oppfinnelsen også på den fordel at den utgår fra prisgunstige startmaterialer, at en oppskalering av prosessen er mulig og at den tillater en lett isolering av sluttproduktene. ;Utgangsmaterialene er handelsvarer eller lette å ;erholde fra kjøpbare forhåndstrinn. Således kan tetra-2,3,4,6-0-benzyl-D-glukopyranose erholdes hos Fluka AG, Buchs, Sveits. Hos Fluka er også metyl-D-mannopyranosid og metyl-D-galaktopyranosid katalogvare. Ved benzylering og spalting av glykosidet kan ;2,3,4,6-tetra-O-benzyl-D-mannose hhv. -galaktose erholdes. ;Via sekvens-metylglykosid-perbenzyl-metylglykosid-perbenzyl-1-OH-sakkaridet kan perbenzyl-l-OH-derivatene av pentosene ribose, arabinose), heksosene og desoksyheksosene (rhamnose, fukose) utvinnes. ;Forbindelsene fremstilt ifølge oppfinnelsen, er verdifulle mellomprodukter innen syntesekjemien. Således kan de f.eks. finne anvendelse for oppbygning av karbohydratdendri-merer, for syntese av NMR-kontrastmidler og for innføring av il ;sukkerrester i farmaka. ;Oppfinnelsen gjelder således en fremgangsmåte for fremstilling av perbenzylerte l-O-glykosider med den generelle formel I ; ; 1 hvilken ;sukker<1>er et monosakkarid som er funksjonalisert i 1-OH-stilling, ;R representerer benzyl, ;n betyr 2, 3 eller 4, ;X betyr -0-, -S-, -C00- eller -NH-, ;og ;L betyr en rettkjedet, forgrenet, mettet eller umettet Ci-Cjø-karbonkjede som eventuelt er avbrutt av 1-10 oksygenatomer, 1-3 svovelatomer, 1-2 fenylen-, 1-2 fenylenoksy-, 1-2 fenylendioksygrupper, en tiofen-, pyrimidin- eller pyridinrest og/eller eventuelt er substituert med 1-3 fenyl-, 1-3 karboksyl-, 1-5 hydroksy-, 1-5 O-C^-CValkyl-, 1-3 aminogrupper, 1- ;3 CF3-grupper eller 1-10 fluoratomer, ;eller deres salter, kjennetegnet ved at et perbenzylert 1-0H-sukker med den generelle formel II ; ; hvori sukker<1>, R og ri har den angitte betydning, ;omsettes med et alkyleringsreagens med den generelle formel ;(III) ; ; hvori Nu betyr en nukleofug, L og X har den nevnte betydning, og Bg representerer en beskyttelsesgruppe, i et organisk løsnings-middel i nærvær av en base og eventuelt en faseoverføringskata-lysator ved en temperatur fra 0-50 °C, hvoretter beskyttelsesgruppen spaltes av og det erholdte reaksjonsprodukt eventuelt overføres til et salt. ;Fremgangsmåten ifølge oppfinnelsen skal i det etter-følgende bli nærmere forklart ved hjelp av utførelseseksempler. ;Eksempel 1 ;2, 3, 4, 6- tetra- O- benzyl- l- O- karboksymetyl- mannopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -mannopyrano se , 1,70 g (5 mmol) tetrabutylammoniumhydrogensulfat og 33,7 g (600 mmol) finpulverisert kaliumhydroksid i 350 ml toluen blir avkjølt til 0 °C. Ved 0 °C tilsetter man dråpevis 29,3 g (150 mmol) bromeddiksyre-tert.-butylester i løpet av 10 minutter under sterk omrøring. Man omrører i 1 time ved 0 °C. Man tilsetter 250 ml MTB (metyl-tert.-butyleter), filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten blir tatt opp i 500 ml etanol. Man tilsetter 40 ml 50%-ig vandig natronlut og koker i 0,5 time under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles pH på 8, og deretter destilleres løs-ningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, ;500 ml eddiksyreetylester og innstiller pH-verdien for den vandige fase på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase enda en gang etterekstrahert med 200 ml eddiksyreetylester. De kom- ;binerte, organiske faser tørkes over magnesiumsulfat, løsnings-midlet destilleres av i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). Fraksjonene som inneholder produkt, blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;50,9 g (85% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. ;Elementæranalyse: ; ; Eksempel 2 ;2, 3, 4, 6- tetra- O- benzyl- 1- O- karboksymetyl- mannopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -mannopy r anose, 1,7 g (5 mmol) tetrabutylammoniumhydrogensulfat og 24 g (600 mmol) finpulverisert natriumhydroksid i 350 ml toluen blir avkjølt til 0 °C. Ved 0 °C tilsetter man 29,3 g (150 mmol) bromeddiksyreetylester dråpevis i løpet av 10 minutter under sterk omrøring. Man omrører i 1 time ved 0 °C. Man tilsetter 250 ml MTB (metyl-tert.-butyleter), filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten blir tatt opp i 500 ml etanol/50 ml vann. Man tilsetter 60 ml 50%-ig vandig natronlut og koker i 4 timer under tilbake-løp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre blir pH innstilt på 8, og deretter blir løsningsmidlet destillert av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt, og den vandige fase blir enda en gang etterekstrahert med 200 ml eddiksyreetylester. De kombinerte, organiske faser blir tørket over magnesiumsulfat, og løsningsmidlet blir destillert av i vakuum og resten kromatografert på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: 48,5 g (81% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. ;Elementæranalyse: ; ; Eksempel 3 ;2, 3, 4, 6- tetra- 0- benzyl- l- 0- karboksymetyl- mannopyranose ;En blanding av 54,1 g {100 mmol) 2,3,4,6-tetra-O-benzyl -mannopyranose, 0,55 g (5 mmol) tetrametylammoniumklorid og 33,7 g (600 mg) finpulverisert kaliumhydroksid i 350 ml benzen avkjøles til 10 "C. Ved 10 °C tilsetter man 35,7 g (160 mmol) 6-bromheksansyreetylester dråpevis i løpet av 10 minutter under sterk omrøring. Man omrører i 2 timer ved 10 °C. Man tilsetter 250 ml MTB (metyl-tert.-butyleter), filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 500 ml etanol/50 ml vann. Man tilsetter 60 ml 50%-ig vandig natronlut og koker i 4 timer under tilbakeløp. Det avkjøles til 0 °C, og pH innstilles på 8 med 10%-ig vandig saltsyre, og deretter blir løsningsmidlet destillert av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser tørkes over magnesiumsulfat, løsningsmidlet destilleres av i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. Utbytte: 51,7 g (79% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. ;Elementæranalyse: ; ; Eksempel 4 ;2, 3, 4, 6- tetra- O- benzyl- 1- 0-( 1- fenyl- l- karboksy- et- 2- yl)-mannopyrano s e ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -mannopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid og 24 g (600 mmol) finpulverisert natriumhydroksid i 350 ml toluen avkjøles til 0 °C. Ved 0 °C tilsetter man 38,6 g (150 mmol) 2-fenyl-3-brompropionsyreetylester oppløst i 30 ml toluen dråpevis i løpet av 10 minutter under sterk omrøring. Man omrører i 1 time ved 0 °C. Man tilsetter 250 ml MTB (metyl-tert.-butyleter), filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten blir tatt opp i 500 ml etanol/50 ml vann. Man tilsetter 60 ml 50%-ig vandig natronlut og koker i 4 timer under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles det på pH 8 og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser tørkes over magnesiumsulfat, løsningsmidlet blir destillert av i vakuum, og resten blir kromatografert på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;54,4 g (79% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. ;Elementæranalyse: ; ; Eksempel 5 ;2, 3, 4, 6- tetra- O- benzyl- l- O- karboksymetyl- mannopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -mannopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid i 350 ml toluen og 150 ml 50%-ig vandig kalilut avkjøles til 0 °C. Ved 0 °C tilsetter man 30,12 g (200 mmol) kloreddiksyre-tert.-butylester dråpevis i løpet av 20 minutter under sterk omrøring. Man omrører i 1 time ved 10 °C. Man tilsetter 250 ml metyl-tert.-butyleter, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 250 ml vann. De kombinerte, organiske fasers løsningsmiddel blir destillert av i vakuum og resten tatt opp i 500 ml etanol. Man tilsetter 40 ml 50%-ig vandig natronlut og koker i 0,5 time under tilbakeløp. Det avkjøles til 0 "C, med 10%-ig saltsyre blir det innstilt på pH 8, og deretter blir løsningsmidlet destillert av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser tørkes over magnesiumsulfat, løsnings-midlet destilleres av i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 2 00 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;41,1 g (82% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. ;Elementæranalyse: ; ; Eksempel 6 ;2, 3, 4, 6- tetra- O- benzyl- l- O- karboksymetyl- glukopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -glukopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid og 24 g (600 mmol) finpulverisert natriumhydroksid i 300 ml tetrahydrofuran avkjøles til 0 °C. Ved 0 °C tilsetter man 78 g (150 rnrnol) 5-tosyloksy-pentankarboksylsyre-tert.-butylester oppløst i 40 ml tetrahydrofuran dråpevis i løpet av 30 minutter under sterk omrøring. Man omrører i 3 timer ved 0 °C. Man tilsetter 300 ml MTB (metyl-tert.-butyleter), filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 500 ml metanol. Man tilsetter 50 ml 50%-ig vandig natronlut og koker i 1 time under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre blir pH innstilt på 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp 1 300 ml vann, 500 ml eddiksyreetylester og innstiller pH-verdien i den vandige fase på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml diklormetan. De kombinerte, organiske faser tørkes over magriesiumsulfat, løs-ningsmidlet destilleres av i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/- eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner inndampes, oppløses i 400 ml eddiksyreetylester og ristes ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;50 g (78% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. ;Elementæranalyse: ; ; Eksempel 7 ;2, 3, 4, 6- tetra- O- benzyl- l- O- karboksymetyl- glukopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -glykopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid i 350 ml toluen og 200 ml 50%-ig vandig natronlut avkjøles til 0 °C. Ved 0 ''C tilsetter man 29,3 g (150 mmol) bromeddiksyre-tert.-butylester dråpevis i løpet av 20 minutter under sterk omrøring. Man omrører i 0,5 time ved 0 °C. Man tilsetter 250 ml toluen, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 150 ml toluen. Løsningsmidlet i de kombinerte, organiske faser blir destillert av i vakuum og resten tatt opp i 400 ml metanol. Man tilsetter 50 ml 50%-ig vandig natronlut og koker i 0,5 time under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles pH på 8, og deretter avdestilleres løsningsmidlet (vakuum). Man tar resten opp i 300 ml vann, 500 ml diklormetan og innstiller den vandige fases pH- verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase enda en gang etterekstrahert med 200 ml diklormetan. De kombinerte, organiske faser tørkes over magnesiumsulfat, løsningsmidlet avdestilleres i vakuum, og resten kromatograferes på silikagel (elueringsmiddel : diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 4 00 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;49,1 g (82% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. ;Elementæranalyse: ; ; Eksempel 8 ;2, 3, 4, 6- tetra- O- benzyl- l- O- karboksymety1- g1ukopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-0-benzyl-glukopyranose, 0,55 g (5 mmol) tetrametylammoniumklorid og 33,7 g (600 mmol) finpulverisert kaliumhydroksid i 350 ml benzen avkjøles til 0 °C. Ved 0 °C tilsetter man 44 g (150 mmol) 11-bromundekansyreetylester oppløst i 50 ml benzen dråpevis i løpet av 30 minutter under sterk omrøring. Man omrører i 2 timer ved 20 °C. Man tilsetter 250 ml metyl-tert.-butyleter, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 500 ml etanol/50 ml vann. Man tilsetter 60 ml 50%-ig vandig natronlut og koker i 5 timer under tilbake-løp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles det på pH 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 500 ml diklormetan og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml diklormetan. De kombinerte, organiske faser blir tørket over magnesiumsulfat, løsningsmidlet blir avdestillert i vakuum, og resten blir kromatografert på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;58,4 g (78% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. ;Elementæranalyse: ; ; Eksempel 9 ;2, 3, 4, 6- tetra- O- benzyl- l- O- karboksyme tyl- galaktopyranose ;En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -mannopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid i 350 ml toluen og 150 ml 50%-ig vandig kalilut avkjøles til 0 °C. Ved 0 °C tilsetter man 3 0,12 g (200 mol) kloreddiksyre-tert.-butylester dråpevis i løpet av 20 minutter under sterk omrøring. Man omrører i 1 time ved 10 °C. Man tilsetter 250 ml metyl-tert.-butyleter, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 250 ml vann. Løsningsmidlet i de kombinerte, organiske faser blir destillert av i vakuum og resten tatt opp i 500 ml etanol. Man tilsetter 40 ml 50%-ig vandig natronlut og koker i 0,5 time under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles det på pH 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser blir tørket over magnesiumsulfat, løsningsmidlet blir avdestillert i vakuum, og resten blir kromatografert på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre - 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. Utbytte: 41,1 g (82% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. ;Elementæranalyse: ; Eksempel 10 ;2, 3, 4, 6- tetra- O- benzyl- l- O-[ 1-( 4- karboksy)- fenyl- prop- 3- yl-galaktopyranose ;En blanding av 54,1 g (100 mol) 2,3,4,6-tetra-O-benzyl-galaktopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid og 24 g (600 mmol) finpulverisert natriumhydroksid i 300 ml tetrahydrofuran avkjøles til 10 °C. Ved 10 °C tilsetter man 43 g (150 mol) 4-(3-metansulfonyloksy-propyl)-benzosyreetylester oppløst i 50 ml tetrahydrofuran dråpevis i løpet av 30 minutter under sterk omrøring. Man omrører i 2 timer ved 10 °C. Man tilsetter 300 ml MTB (metyl-tert.-butyleter), filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten blir tatt opp i 500 ml metanol/50 ml vann. Man tilsetter 60 ml 50%-ig vandig natronlut og koker i 5 timer under til-bakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles det på pH 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser blir tørket over magnesiumsulfat, løsningsmidlet blir avdestillert i vakuum, og resten blir kromatografert på silikagel (elueringsmiddel : diklormetan/n-heksan/etanol/eddiksyre = 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 400 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. ;Utbytte: ;54,1 g (77% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. ;Elementæranalyse: ; ; Eksempel 11 ;2, 3, 5- tri- Q- benzyl- l- 0- karboksymetyl- ribo£uranose ;En blanding av 42,1 g (100 mmol) 2,3,5-tri-O-ribofuranose, 1,39 g (5 mmol) tetrabutylammoniumklorid i 350 ml toluen og 200 ml 50%-ig vandig natronlut avkjøles til 0 °C. Ved 0 °C tilsetter man 29,3 g (150 mmol) bromeddiksyre-tert.-butyl-ester dråpevis i løpet av 20 minutter under sterk omrøring. Man omrører i 1 time ved 0 °C. Man tilsetter 250 ml metyl-tert.-butyleter, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 200 ml metyl-tert.-butyleter. Løs-ningsmidlet i de kombinerte, organiske faser blir destillert av 1 vakuum og resten tatt opp i 500 ml etanol. Man tilsetter 50 ml 50%-ig vandig natronlut og koker i 0,5 time under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles det på pH 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 500 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase blir fraskilt og den vandige fase etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser blir tørket over magnesiumsulfat, løsningsmidlet blir avdestillert i vakuum, og resten blir kromatografert på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre * 20:5:3:0,5). De produktholdige fraksjoner blir inndampet, oppløst i 200 ml eddiksyreetylester og ristet ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. Utbytte: 39,2 g (82% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. Quaternary ammonium or phosphonium salts known for this purpose or also crown ethers, such as e.g. [15]-krona-5- or [18]-krona-6. Preferably, quaternary ammonium salts with four identical or different hydrocarbon groups on the cation selected from methyl, ethyl, propyl, isopropyl, butyl or isobutyl are mentioned. The hydrocarbon groups on the cation must be sufficiently large to ensure good solubility of the alkylating reagent in the organic solvent. According to the invention, N(butyl)4<+->Cl", N (butyl) 4+-HS04", but also N (methyl) 4*-Cl" are preferably used. After the reaction has taken place, work-up can the reaction mixture takes place by isolation of the still protected end product and with subsequent normal cleavage of the protecting group to the end product with the general formula I. However, it is preferred that the still protected end product is not isolated, but that the solvent is removed, that the residue is taken up in a new solvent which is suitable for the removal of the protecting group and that the removal is carried out here. The procedure for removing the protective group and for the regeneration of the acid, amino, hydroxy or thiol group is well known to the person skilled in the art. an acid protecting group that blocks the acidic proton of the carboxyl group, i.e. for example if methyl, ethyl, benzyl or tert.-butyl, the acid is regenerated in the usual way with the help of alkaline hyd Rolyse. In the method according to the invention, in this case the residue, after removal of the solvent from the alkylation reaction, is taken up in a new solvent, e.g. methanol, ethanol, tetrahydrofuran, isopropanol, butanol or dioxane. An aqueous solution of a base is then added, and the alkaline hydrolysis is carried out at temperatures from 0-100 °C. As hydroxy protecting groups, e.g. benzyl, 4-methoxybenzyl, 4-nitrobenzyl, trityl, diphenylmethyl, trimethylsilyl, dimethyl-tert-butylsilyl or diphenyl-tert-butylsilyl groups in question. The hydroxy groups can also be present, e.g. as THP ether, t-Alkoxyethyl ether, MEM ether or also as ester with aromatic or aliphatic carboxylic acids, such as e.g. acetic acid or benzoic acid. In the case of polyols, the hydroxy groups can also be protected in the form of ketals with e.g. acetone, acetaldehyde, cyclohexanone or benzaldehyde. The hydroxy protecting groups can according to literature methods known to the person skilled in the art, e.g. by hydrogenolysis, acid treatment of the ethers and ketals, alkali treatment of the esters, or treatment of the silyl protecting groups with fluoride, are released (see, e.g., Protective Groups in Organic Syntheses, 2nd ed., T.W. Greene and P.G.M. Wuts, John Wiley & Sons, Inc., New York, 1991). ;The thiol groups can be protected as benzyl ethers which are cleavable with sodium in ammonia or boiling ethanol (W.J. Patterson, v. du Vigneaud, J. Biol. Chem. 111:393, 1993). S-tert-butyl ethers are readily cleaved with hydrogen fluoride/anisole at room temperature (S. Salzakibona et al., Bull. Chem. Soc. Japn., 40:2164 (1967)]. S-benzyloxycarbonyl derivatives can be conveniently cleaved with concentrated ammonia solution at room temperature (A. Berger et al., J. Am. Chem. Soc, 78:4483, 1956). Only at boiling temperatures that ur, S-benzyloxycarbonyl derivatives of trifluoroacetic acid are cleaved [L. Zervas et al., J. Am . Chem. Soc, 85:1337 (1963)]. The NH 2 groups can be protected in many ways and again released. The N-trifluoroacetyl derivative is cleaved with potassium or sodium carbonate in water [H. Newman, J. Org. Chem. , 30:287 (1965), M.A. Schwartz et al., J. Am. Chem. Soc, 95 G12 (1973)] or simply by ammonia solution [M. Imazama and F. Eckstein, J. Org. Chem. , 44:2039 (1979)]. Likewise, the tert-butyloxycarbonyl derivative is easily cleaved. Stirring with trifluoroacetic acid is sufficient [B.F. Lundt et al., J. Org. Chem., 43:2285 (1978)]. The group ofNH2 protecting groups that can be cleaved hydrogenolytically or reductively are very large: the N-benzyl group can be conveniently cleaved with hydrogen/Pd-C [W.H. Hartung and R. Simonoff, Org. Reactions VII, 263 (1953)], which also applies to the trityl group [L. Zervas et al., J. Am. Chem. Soc, 78:1359 (1956)] and the benzyloxycarbonyl group [M. Bergmann and L. Zervas, Ber. 65:1192 (1932)]. Of the silyl derivatives, the easily cleavable tert-butyldiphenyl-silyl compounds [L.E. Overman et al., Tetrahedron Lett., 27:4391 (1986)] as well as the 2-(trimethylsilyl)-ethyl carbamates [L. Grehn et al., Angew. Chem. Int Ed. Engl., 23:296 (1983)] and the 2-trimethylsilyletanesulfonamides [R.S. Garigipati and S.M. Weinreb, J. Org. Chem., 53:4134 (1988)] used, which can be cleaved with fluoride ions. 9-Fluorenylmethylcarbamate is particularly easily cleavable. The cleavage takes place with amines, such as piperidine, morpholine, 4-dimethylaminopyridine, but also with tetrabutylammonium fluoride [L.A. Corpino et al., J. Org. Chem., 55:1673 (1990); M. Ueki and M. Amemiya, Tetrahedron Lett., 28:6617 (1987)]. The isolation of the final product obtained with the general formula I (alcohol, thiol, amine or carboxylic acid) also takes place - according to usual methods which are well known to the person skilled in the art. Thus, e.g. in the case of the acid protecting group, the solvent evaporated from the hydrolysis reaction and the residue taken up in an aprotic solvent. When acidifying with an aqueous acid solution, the pH is set to approx. 2-4, and then the organic phase is separated. The perbenzylated 1-0-glycoside can now be recovered by crystallization or chromatography. Optionally, the obtained compounds of the general formula I can also be converted to their salts in the usual way. The yields of the compounds of the general formula I, which can be obtained with the method according to the invention, are good. For known compounds, for which a comparison with the state of the art is possible, they lie above the yields according to the state of the art. Thus, e.g. for 1-0-acetic acid of perbenzylated glucose an overall yield of 59% described in Angew. Chem. 1998, 110 (24), p. 3634, with the method mentioned there, while according to the invention the yield for this compound over 2 steps amounts to 82% (cf. example 7 in the present patent application). The preparation of the compound according to example 12 in the present patent application is also described in this publication. While the yield of this compound is 78% according to the invention over 2 steps, with the method described in the publication, only 45% is obtained. In addition to the high yields, the method according to the invention also offers the advantage that it starts from inexpensive starting materials, that an upscaling of the process is possible and that it allows easy isolation of the end products. The starting materials are commercial goods or easy to obtain from purchasable precursors. Thus, tetra-2,3,4,6-0-benzyl-D-glucopyranose can be obtained from Fluka AG, Buchs, Switzerland. At Fluka, methyl-D-mannopyranoside and methyl-D-galactopyranoside are also catalog items. By benzylation and cleavage of the glycoside, 2,3,4,6-tetra-O-benzyl-D-mannose or -galactose is obtained. ;Via the sequence methylglycoside-perbenzyl-methylglycoside-perbenzyl-1-OH-saccharide, the perbenzyl-l-OH derivatives of the pentoses ribose, arabinose), the hexoses and the deoxyhexoses (rhamnose, fucose) can be recovered. The compounds produced according to the invention are valuable intermediates in synthetic chemistry. Thus, they can e.g. find application for the construction of carbohydrate dendrimers, for the synthesis of NMR contrast agents and for the introduction of sugar residues in pharmaceuticals. The invention thus relates to a process for the production of perbenzylated 1-O-glycosides with the general formula I; ; 1 which ;sugar<1>is a monosaccharide functionalized in the 1-OH position, ;R represents benzyl, ;n means 2, 3 or 4, ;X means -0-, -S-, -C00- or - NH-, ;and ;L means a straight-chain, branched, saturated or unsaturated Ci-Cj carbon chain which is optionally interrupted by 1-10 oxygen atoms, 1-3 sulfur atoms, 1-2 phenylene-, 1-2 phenyleneoxy-, 1- 2 phenylenedioxy groups, a thiophene, pyrimidine or pyridine residue and/or is optionally substituted with 1-3 phenyl-, 1-3 carboxyl-, 1-5 hydroxy-, 1-5 O-C^-CV alkyl-, 1-3 amino groups, 1- ;3 CF3 groups or 1-10 fluorine atoms, ;or their salts, characterized in that a perbenzylated 1-OH-sugar of the general formula II ; ; wherein sugar<1>, R and ri have the indicated meaning, ;is reacted with an alkylating reagent of the general formula ;(III) ; ; wherein Nu means a nucleofuge, L and X have the aforementioned meaning, and Bg represents a protecting group, in an organic solvent in the presence of a base and optionally a phase transfer catalyst at a temperature from 0-50 °C, after which the protecting group is cleaved of and the reaction product obtained is optionally transferred to a salt. The method according to the invention will be explained in more detail in the following with the help of design examples. ;Example 1 ;2,3,4,6-tetra-O-benzyl-1-O-carboxymethyl- mannopyranose ;A mixture of 54.1 g (100 mmol) of 2,3,4,6-tetra-O-benzyl -mannopyrano se , 1.70 g (5 mmol) of tetrabutylammonium hydrogen sulfate and 33.7 g (600 mmol) of finely powdered potassium hydroxide in 350 ml of toluene are cooled to 0 °C. At 0 °C, 29.3 g (150 mmol) of bromoacetic acid tert-butyl ester are added dropwise over the course of 10 minutes with vigorous stirring. The mixture is stirred for 1 hour at 0 °C. 250 ml MTB (methyl tert-butyl ether) is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The residue is taken up in 500 ml of ethanol. 40 ml of 50% aqueous caustic soda is added and boiled for 0.5 hour under reflux. It is cooled to 0 °C, the pH is adjusted to 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml water, 500 ml acetic acid ethyl ester and the pH value for the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is once again post-extracted with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The fractions containing product are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. ;Yield: ;50.9 g (85% of theoretical, over 2 steps) of a colorless, viscous oil. ;Elementary analysis: ; ; Example 2; 2, 3, 4, 6-tetra-O-benzyl-1-O-carboxymethyl-mannopyranose; A mixture of 54.1 g (100 mmol) 2,3,4,6-tetra-O-benzyl - mannopyranose, 1.7 g (5 mmol) tetrabutylammonium hydrogen sulfate and 24 g (600 mmol) finely powdered sodium hydroxide in 350 ml toluene are cooled to 0 °C. At 0 °C, 29.3 g (150 mmol) of bromoacetic acid ethyl ester are added dropwise over 10 minutes with vigorous stirring. The mixture is stirred for 1 hour at 0 °C. 250 ml MTB (methyl tert-butyl ether) is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The remainder is taken up in 500 ml ethanol/50 ml water. 60 ml of 50% aqueous caustic soda is added and boiled for 4 hours under reflux. It is cooled to 0 °C, the pH is adjusted to 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated, and the aqueous phase is once again post-extracted with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, and the solvent is distilled off in vacuo and the residue chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. Yield: 48.5 g (81% of theory, over 2 steps) of a colorless viscous oil. ;Elementary analysis: ; ; Example 3; 2, 3, 4, 6-tetra-O-benzyl-1-O-carboxymethyl-mannopyranose; A mixture of 54.1 g (100 mmol) 2,3,4,6-tetra-O-benzyl - mannopyranose, 0.55 g (5 mmol) tetramethylammonium chloride and 33.7 g (600 mg) finely powdered potassium hydroxide in 350 ml benzene are cooled to 10 °C. At 10 °C, 35.7 g (160 mmol) 6-bromohexanoic acid ethyl ester is added dropwise during 10 minutes under vigorous stirring. Stir for 2 hours at 10 °C. Add 250 ml of MTB (methyl tert-butyl ether), filter off the solid and evaporate the filtrate to dryness in vacuo. The residue is taken up in 500 ml of ethanol/50 ml of water. 60 ml of 50% aqueous sodium hydroxide solution is added and refluxed for 4 hours. It is cooled to 0 °C, and the pH is adjusted to 8 with 10% aqueous hydrochloric acid, and then the solvent distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and d an aqueous phase then extracted once more with 200 ml ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. Yield: 51.7 g (79% of theory, over 2 steps) of a colorless solid. ;Elementary analysis: ; ; Example 4: 2, 3, 4, 6-tetra-O-benzyl-1-0-(1-phenyl-1-carboxy-et-2-yl)-mannopyrano s e ; A mixture of 54.1 g (100 mmol ) 2,3,4,6-tetra-O-benzyl-mannopyranose, 1.39 g (5 mmol) tetrabutylammonium chloride and 24 g (600 mmol) finely powdered sodium hydroxide in 350 ml toluene are cooled to 0 °C. At 0 °C, 38.6 g (150 mmol) of 2-phenyl-3-bromopropionic acid ethyl ester dissolved in 30 ml of toluene are added dropwise over 10 minutes with vigorous stirring. The mixture is stirred for 1 hour at 0 °C. 250 ml MTB (methyl tert-butyl ether) is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The remainder is taken up in 500 ml ethanol/50 ml water. 60 ml of 50% aqueous caustic soda is added and boiled for 4 hours under reflux. It is cooled to 0 °C, adjusted to pH 8 with 10% aqueous hydrochloric acid and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. Yield: 54.4 g (79% of theory, over 2 steps) of a colorless solid. ;Elementary analysis: ; ; Example 5; 2, 3, 4, 6-tetra-O-benzyl-1-O-carboxymethyl-mannopyranose; A mixture of 54.1 g (100 mmol) 2,3,4,6-tetra-O-benzyl - mannopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride in 350 ml of toluene and 150 ml of 50% aqueous potassium hydroxide are cooled to 0 °C. At 0 °C, 30.12 g (200 mmol) of chloroacetic acid tert-butyl ester are added dropwise over the course of 20 minutes with vigorous stirring. The mixture is stirred for 1 hour at 10 °C. 250 ml of methyl tert-butyl ether is added, the organic phase is separated and the aqueous phase is extracted twice with 250 ml of water. The solvent of the combined organic phases is distilled off in vacuo and the residue taken up in 500 ml of ethanol. 40 ml of 50% aqueous caustic soda is added and boiled for 0.5 hour under reflux. It is cooled to 0 "C, with 10% hydrochloric acid it is adjusted to pH 8, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted at pH 2 (10% aqueous hydrochloric acid) with stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5).The product-containing fractions are evaporated, dissolved in 400 ml of ethyl acetate and shaken out 3 times with 200 ml of water. The organic phase is then separated and evaporated to dryness in vacuo. ;Yield: ;41.1 g (82% of the theoretical, over 2 steps) of a colorless, viscous oil. ;Elementary analysis: ; ;Example 6 ;2, 3 , 4, 6- tetra- O- benzyl- l- O- carboxymethyl- glucopyranose; A mixture of 54, 1 g (100 mmol) of 2,3,4,6-tetra-O-benzyl-glucopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride and 24 g (600 mmol) of finely powdered sodium hydroxide in 300 ml of tetrahydrofuran are cooled to 0 °C. At 0 °C, 78 g (150 mmol) of 5-tosyloxy-pentanecarboxylic acid tert-butyl ester dissolved in 40 ml of tetrahydrofuran are added dropwise over the course of 30 minutes with vigorous stirring. The mixture is stirred for 3 hours at 0 °C. 300 ml MTB (methyl tert-butyl ether) is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The residue is taken up in 500 ml of methanol. Add 50 ml of 50% aqueous caustic soda and boil for 1 hour under reflux. It is cooled to 0 °C, the pH is adjusted to 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up with 1,300 ml of water, 500 ml of acetic acid ethyl ester and the pH value in the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml of dichloromethane. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. ;Yield: ;50 g (78% of theoretical, over 2 steps) of a colorless solid. ;Elementary analysis: ; ; Example 7; 2, 3, 4, 6-tetra-O-benzyl-1-O-carboxymethyl-glucopyranose; A mixture of 54.1 g (100 mmol) 2,3,4,6-tetra-O-benzyl - glycopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride in 350 ml of toluene and 200 ml of 50% aqueous sodium hydroxide solution are cooled to 0 °C. At 0 °C, 29.3 g (150 mmol) of bromoacetic acid tert-butyl ester are added dropwise over the course of 20 minutes with vigorous stirring. The mixture is stirred for 0.5 hour at 0 °C. 250 ml of toluene is added, the organic phase is separated and the aqueous phase is extracted twice with 150 ml of toluene. The solvent in the combined organic phases is distilled off in vacuo and the residue taken up in 400 ml of methanol. Add 50 ml of 50% aqueous caustic soda and boil for 0.5 hour under reflux. It is cooled to 0 °C, the pH is adjusted to 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of dichloromethane and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase once more post-extracted with 200 ml of dichloromethane. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml of ethyl acetate and shaken out 3 times with 200 ml of water. The organic phase is then separated and evaporated to dryness in a vacuum. ;Yield: ;49.1 g (82% of theoretical, over 2 steps) of a colorless, viscous oil. ;Elementary analysis: ; ; Example 8; 2, 3, 4, 6-tetra-O-benzyl-1-O-carboxymethyl-glucopyranose; A mixture of 54.1 g (100 mmol) of 2,3,4,6-tetra-O-benzyl- glucopyranose, 0.55 g (5 mmol) tetramethylammonium chloride and 33.7 g (600 mmol) finely powdered potassium hydroxide in 350 ml benzene are cooled to 0 °C. At 0 °C, 44 g (150 mmol) of 11-bromodecanoic acid ethyl ester dissolved in 50 ml of benzene are added dropwise over the course of 30 minutes with vigorous stirring. The mixture is stirred for 2 hours at 20 °C. 250 ml of methyl tert-butyl ether is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The remainder is taken up in 500 ml ethanol/50 ml water. 60 ml of 50% aqueous caustic soda is added and boiled for 5 hours under reflux. It is cooled to 0 °C, adjusted to pH 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of dichloromethane and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml of dichloromethane. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. Yield: 58.4 g (78% of theory, over 2 steps) of a colorless solid. ;Elementary analysis: ; ; Example 9; 2, 3, 4, 6-tetra-O-benzyl-1-O-carboxymethyl-galactopyranose; A mixture of 54.1 g (100 mmol) of 2,3,4,6-tetra-O-benzyl -mannopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride in 350 ml of toluene and 150 ml of 50% aqueous potassium hydroxide are cooled to 0 °C. At 0 °C, 3 0.12 g (200 mol) of chloroacetic acid tert-butyl ester are added dropwise over the course of 20 minutes with vigorous stirring. The mixture is stirred for 1 hour at 10 °C. 250 ml of methyl tert-butyl ether is added, the organic phase is separated and the aqueous phase is extracted twice with 250 ml of water. The solvent in the combined organic phases is distilled off in vacuo and the residue taken up in 500 ml of ethanol. 40 ml of 50% aqueous caustic soda is added and boiled for 0.5 hour under reflux. It is cooled to 0 °C, adjusted to pH 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid - 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. Yield: 41.1 g (82% of theory, over 2 steps) of a colorless viscous oil. ;Elementary analysis: ; Example 10; 2, 3, 4, 6-tetra-O-benzyl-1-O-[1-(4-carboxy)-phenyl-prop-3-yl-galactopyranose; A mixture of 54.1 g (100 mol ) 2,3,4,6-tetra-O-benzyl-galactopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride and 24 g (600 mmol) of finely powdered sodium hydroxide in 300 ml of tetrahydrofuran are cooled to 10 °C. At 10 °C, 43 g (150 mol) of 4-(3-methanesulfonyloxy-propyl)-benzoic acid ethyl ester dissolved in 50 ml of tetrahydrofuran are added dropwise over the course of 30 minutes with vigorous stirring. The mixture is stirred for 2 hours at 10 °C. 300 ml MTB (methyl tert-butyl ether) is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The remainder is taken up in 500 ml methanol/50 ml water. 60 ml of 50% aqueous caustic soda is added and boiled for 5 hours under reflux. It is cooled to 0 °C, adjusted to pH 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum. Yield: 54.1 g (77% of theory, over 2 steps) of a colorless solid. ;Elementary analysis: ; ; Example 11; 2, 3, 5-tri-Q-benzyl-1-O-carboxymethyl-ribo£uranose; A mixture of 42.1 g (100 mmol) 2,3,5-tri-O-ribofuranose, 1, 39 g (5 mmol) of tetrabutylammonium chloride in 350 ml of toluene and 200 ml of 50% aqueous caustic soda are cooled to 0 °C. At 0 °C, 29.3 g (150 mmol) of bromoacetic acid tert-butyl ester are added dropwise over the course of 20 minutes with vigorous stirring. The mixture is stirred for 1 hour at 0 °C. 250 ml of methyl tert-butyl ether are added, the organic phase is separated and the aqueous phase is extracted twice with 200 ml of methyl tert-butyl ether. The solvent in the combined organic phases is distilled by 1 vacuum and the residue taken up in 500 ml of ethanol. Add 50 ml of 50% aqueous caustic soda and boil for 0.5 hour under reflux. It is cooled to 0 °C, adjusted to pH 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 500 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated and the aqueous phase is extracted once more with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid * 20:5:3:0.5). The product-containing fractions are evaporated, dissolved in 200 ml of acetic acid ethyl ester and shaken out 3 times with 200 ml of water. The organic phase is then separated and evaporated to dryness in vacuo. Yield: 39.2 g (82% of the theoretical, over 2 steps) of a colourless, viscous oil.
Elementæranalyse: Elemental analysis:
Eksempel 12 Example 12
2, 3, 5- tri- O- benzyl- l- O-( l- amino- et- 2- yl)- ribofuranose 2, 3, 5- tri- O- benzyl- l- O-( l-amino-et- 2- yl)- ribofuranose
En blanding av 42,1 g (100 mmol) 2,3,5-tri-O-benzyl-ribof uranose , 3,40 g (10 mmol) tetrabutylammoniumhydrogensulfat og 33,7 g (600 mmol) finpulverisert kaliumhydroksid i 350 ml benzen avkjøles til 10 °C. Ved 10 °C tilsetter man 38,1 g A mixture of 42.1 g (100 mmol) 2,3,5-tri-O-benzyl-ribof uranose, 3.40 g (10 mmol) tetrabutylammonium hydrogen sulfate and 33.7 g (600 mmol) finely powdered potassium hydroxide in 350 ml benzene cool to 10 °C. At 10 °C, 38.1 g is added
(150 mmol) N-(2-brometyl)-ftalimid oppløst i 100 ml benzen dråpevis i løpet av 40 minutter under sterk omrøring. Man omrører i 3 timer ved 10 °C. Man tilsetter 300 ml benzen, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Filtratresten oppløses i 500 ml etanol, 25,03 g hydrazinhydrat (500 mmol) tilsettes, og det oppvarmes i 6 timer under tilbakeløp. Man lar avkjøle til 0 "C, filtrerer av fra det utfelte bunnfall og inndamper filtratet til tørrhet i vakuum. Resten oppløses i 400 ml diklormetan, og denne løsning blir vasket 2 ganger med 5%-ig vandig natronlut og deretter én gang med vann (hver gang 300 ml). Den organiske fase inndampes til tørrhet i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/etanol/trietylamin = 20:2:0,1). Utbytte: 36,2 g (78% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. (150 mmol) of N-(2-bromomethyl)-phthalimide dissolved in 100 ml of benzene dropwise over 40 minutes with vigorous stirring. The mixture is stirred for 3 hours at 10 °C. 300 ml of benzene are added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The filtrate residue is dissolved in 500 ml of ethanol, 25.03 g of hydrazine hydrate (500 mmol) is added, and it is heated for 6 hours under reflux. It is allowed to cool to 0 "C, the precipitate that has formed is filtered off and the filtrate is evaporated to dryness in vacuo. The residue is dissolved in 400 ml of dichloromethane, and this solution is washed twice with 5% aqueous sodium hydroxide solution and then once with water ( each time 300 ml). The organic phase is evaporated to dryness in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/ethanol/triethylamine = 20:2:0.1). Yield: 36.2 g (78% of the theoretical , over 2 steps) of a colorless solid.
Elementæranalyse: Elemental analysis:
Eksempel 13 2, 3, 4, 6- tetra- O- benzyl- l- O-( l- amino- prop- 3- yl)- galaktopyranose En blanding av 42,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl-galaktopyranose, 1,7 g (5 mmol) tetrabutylammoniumhydrogensulfat og 33,7 g (600 mmol) finpulverisert kaliumhydroksid i 350 ml benzen avkjøles til 10 °C. Ved 10 °C tilsetter man 40,2 g (150 mmol) N-(3-brompropyl)-ftalimid oppløst i 100 ml benzen dråpevis i løpet av 40 minutter under sterk omrøring. Man om-rører i 3 timer ved 10 °C. Man tilsetter 300 ml benzen, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Filtratresten oppløses i 500 ml etanol, og 25,03 ml hydrazinhydrat (500 mmol) tilsettes, og det oppvarmes i 6 timer under tilbakeløp. Man lar avkjøle til 0 °C, filtrerer av fra det utfelte bunnfall og inndamper filtratet til tørrhet i vakuum. Resten oppløses i 400 ml diklormetan, og denne løsning vaskes 2 ganger med 5%-ig vandig natronlut og deretter én gang med vann (hver gang 300 ml). Den organiske fase inndampes til tørrhet i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/etanol/trietylamin = 20:2:0,1). Example 13 2,3,4,6-tetra-O-benzyl-1-O-(1-amino-prop-3-yl)-galactopyranose A mixture of 42.1 g (100 mmol) 2,3,4, 6-tetra-O-benzyl-galactopyranose, 1.7 g (5 mmol) of tetrabutylammonium hydrogen sulfate and 33.7 g (600 mmol) of finely powdered potassium hydroxide in 350 ml of benzene are cooled to 10 °C. At 10 °C, 40.2 g (150 mmol) of N-(3-bromopropyl)-phthalimide dissolved in 100 ml of benzene are added dropwise over the course of 40 minutes with vigorous stirring. The mixture is stirred for 3 hours at 10 °C. 300 ml of benzene are added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The filtrate residue is dissolved in 500 ml of ethanol, and 25.03 ml of hydrazine hydrate (500 mmol) is added, and it is heated for 6 hours under reflux. Allow to cool to 0 °C, filter off the precipitate and evaporate the filtrate to dryness in a vacuum. The residue is dissolved in 400 ml of dichloromethane, and this solution is washed twice with 5% aqueous caustic soda and then once with water (each time 300 ml). The organic phase is evaporated to dryness in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/ethanol/triethylamine = 20:2:0.1).
Utbytte: Dividend:
46 g {77% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. 46 g {77% of theory, over 2 steps) of a colorless solid.
Elementæranalyse: Elemental analysis:
Eksempel 14 Example 14
2, 3, 4, 6- tetra- O- benzyl- 1- 0-{ l- amino- heks- 6- yl)- mannopyranose 2,3,4,6-tetra-O-benzyl-1-O-{1-amino-hex-6-yl)-mannopyranose
En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-0-benzyl-mannopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid i 350 ml diklormetan og 200 ml 60%-ig vandig kalilut avkjøles til 0 °C. Ved 0 °C tilsetter man 60,3 g (150 mmol) 6-bromheksylamin-N-(9-fluorenyImetoksy-karbonyl) dråpevis i løpet av 30 minutter under sterk omrøring. Man omrører i 1 time ved 0 °C. Man tilsetter 300 ml diklormetan, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 200 ml diklormetan. Løsningsmidlet i de kombinerte, organiske faser destilleres av i vakuum. Resten tas opp i 250 ml etanol, og 100 g (1,17 mol) piperidin blir tilsatt. Man omrører i 5 timer ved 40 °C. Oppløs-ningen inndampes til tørrhet, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/etanol/trietylamin 20:2:0,1). A mixture of 54.1 g (100 mmol) of 2,3,4,6-tetra-0-benzyl-mannopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride in 350 ml of dichloromethane and 200 ml of 60% aqueous potassium hydroxide is cooled to 0 °C. At 0 °C, 60.3 g (150 mmol) of 6-bromohexylamine-N-(9-fluorenylmethoxycarbonyl) are added dropwise over the course of 30 minutes with vigorous stirring. The mixture is stirred for 1 hour at 0 °C. 300 ml of dichloromethane is added, the organic phase is separated and the aqueous phase is extracted twice with 200 ml of dichloromethane. The solvent in the combined organic phases is distilled off in a vacuum. The residue is taken up in 250 ml of ethanol, and 100 g (1.17 mol) of piperidine are added. The mixture is stirred for 5 hours at 40 °C. The solution is evaporated to dryness, and the residue is chromatographed on silica gel (eluent: dichloromethane/ethanol/triethylamine 20:2:0.1).
Utbytte: Dividend:
41,1 g (79% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. 41.1 g (79% of theory, over 2 steps) of a colorless solid.
Elementæranalyse: Elemental analysis:
Eksempel 15 Example 15
2, 3, 4- tri- 0- benzyl- 6- desoksy- l- 0-( l- amjno- but- 4- yl)- fukopyranose 2, 3, 4-tri-O-benzyl-6-deoxy-1-O-(1-amino-but-4-yl)-fucopyranose
En blanding av 43,5 g (100 mmol) 2,3,4-tri-O-benzyl-e-desoksy-f ukopyranose, 1,7 g (5 mmol) tetrabutylammoniumhydrogensulfat i 350 ml diklormetan og 200 ml 60%-ig vandig natronlut avkjøles til 0 °C. Ved 10 °C tilsetter man 47,4 g (150 mmol) 2-(trimetylsilyl)-etylsulfonsyre-N-(4-brombutyl)-amid oppløst i 100 ml diklormetan dråpevis i løpet av 30 minutter under sterk omrøring. Man omrører i 2 timer 10 °C. Man tilsetter 300 ml diklormetan, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 200 ml diklormetan. Løsningsmidlet i de kombinerte, organiske faser destilleres av i vakuum. Resten tas opp i 350 ml acetonitril, og 52,3 g (200 mmol) tetrabutylammoniumfluorid som monohydrat tilsettes. Man omrører i 3 timer ved 50 °C. Oppløsningen konsentreres til tørrhet, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/etan-ol/trietylamin = 20:2:0,1). A mixture of 43.5 g (100 mmol) of 2,3,4-tri-O-benzyl-e-deoxy-fucopyranose, 1.7 g (5 mmol) of tetrabutylammonium hydrogen sulfate in 350 ml of dichloromethane and 200 ml of 60%-ig aqueous caustic soda is cooled to 0 °C. At 10 °C, 47.4 g (150 mmol) of 2-(trimethylsilyl)-ethylsulfonic acid-N-(4-bromobutyl)-amide dissolved in 100 ml of dichloromethane are added dropwise over the course of 30 minutes with vigorous stirring. The mixture is stirred for 2 hours at 10 °C. 300 ml of dichloromethane is added, the organic phase is separated and the aqueous phase is extracted twice with 200 ml of dichloromethane. The solvent in the combined organic phases is distilled off in a vacuum. The residue is taken up in 350 ml of acetonitrile, and 52.3 g (200 mmol) of tetrabutylammonium fluoride as monohydrate is added. The mixture is stirred for 3 hours at 50 °C. The solution is concentrated to dryness, and the residue is chromatographed on silica gel (eluent: dichloromethane/ethanol/triethylamine = 20:2:0.1).
Utbytte: Dividend:
39,4 g (78% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. 39.4 g (78% of theory, over 2 steps) of a colorless solid.
Elementæranalyse: Elemental analysis:
Eksempel 16 Example 16
2, 3, 4, 6- tetra- O- benzyl- 1- 0-( 3, 6, 9, 12, 15- pentaoksa- l- karboksy-heksadek- 16- yl)- glukopyranose 2, 3, 4, 6- tetra- O- benzyl- 1- 0-( 3, 6, 9, 12, 15- pentaoxa- l- carboxy- hexadecyl- 16- yl)- glucopyranose
En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -glukopyranose, 1,3 9 g (5 mmol) tetrabutylammoniumklorid og 24 g (600 mmol) finpulverisert natriumhydroksid i 350 ml toluen avkjøles til 0 °C. Ved 0 °C tilsetter man 64,3 g (130 mmol) 17-tosyloksy-3,6,9,12,15-pentaoksaheptadekansyre-etylester oppløst i 100 ml tetrahydrofuran dråpevis i løpet av 50 minutter under sterk omrøring. Man omrører i 3 timer ved 0 °C. Man tilsetter 300 ml diklormetan, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 500 ml etanol/100 ml vann. Man tilsetter 60 ml 60%-ig vandig natronlut og koker i 5 timer under tilbakeløp. Det avkjøles til 0 °C, og med 10%-ig vandig saltsyre innstilles det på pH 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 400 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 2 (10%-ig vandig saltsyre) under omrøring. Den organiske fase fraskilles, og den vandige fase blir etterekstrahert enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser tørkes over magnesiumsulfat, løsningsmidlet destilleres av i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol/eddiksyre = 20:8:5:0,5). De produktholdige fraksjoner inndampes, oppløses i 400 ml eddiksyreetylester og ristes ut 3 ganger med 200 ml vann. Deretter blir den organiske fase fraskilt og inndampet til tørrhet i vakuum. A mixture of 54.1 g (100 mmol) of 2,3,4,6-tetra-O-benzyl-glucopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride and 24 g (600 mmol) of finely powdered sodium hydroxide in 350 ml of toluene cool to 0 °C. At 0 °C, 64.3 g (130 mmol) of 17-tosyloxy-3,6,9,12,15-pentaoxaheptadecanoic acid ethyl ester dissolved in 100 ml of tetrahydrofuran are added dropwise over the course of 50 minutes with vigorous stirring. The mixture is stirred for 3 hours at 0 °C. 300 ml of dichloromethane is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The remainder is taken up in 500 ml ethanol/100 ml water. 60 ml of 60% aqueous caustic soda is added and boiled for 5 hours under reflux. It is cooled to 0 °C, and with 10% aqueous hydrochloric acid it is adjusted to pH 8, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 400 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 2 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated, and the aqueous phase is then extracted once more with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol/acetic acid = 20:8:5:0.5). The product-containing fractions are evaporated, dissolved in 400 ml ethyl acetate and shaken out 3 times with 200 ml water. The organic phase is then separated and evaporated to dryness in a vacuum.
Utbytte: Dividend:
64,3 g (77% av det teoretiske, over 2 trinn) av en fargeløs ol je. 64.3 g (77% of the theoretical, over 2 steps) of a colorless oil.
Elementæranalyse: Elemental analysis:
Eksempel 17 Example 17
2, 3, 4, 6- tetra- O- benzyl- l- O-( l- hydroksy- et- 2- yl)- mannopyranose 2, 3, 4, 6- tetra- O- benzyl- l- O-( l- hydroxy- et- 2- yl)- mannopyranose
En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -mannopyranose , 1,7 g (5 mmol) tetrabutylammoniumhydrogensulfat og 33,7 g (600 mmol) finpulverisert kaliumhydroksid i 350 ml benzen avkjøles til 0 °C. Ved 0 °C tilsetter man 31,4 g (150 mmol) 2,2-dimetyl-propionsyre-2-brometylester dråpevis i løpet av 30 minutter under sterk omrøring. Han omrører i 2 timer ved 0 °C. Man tilsetter 300 ml benzen, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 500 ml etanol/100 ml vann. Man tilsetter 100 ml 50%-ig vandig kalilut og koker i 8 timer under tilbakeløp. Det avkjøles til 0 °C, med 10%-ig vandig saltsyre innstilles det på pH 8, og deretter destilleres løsningsmidlet av (vakuum). Man tar resten opp i 300 ml vann, 400 ml eddiksyreetylester og innstiller den vandige fases pH-verdi på pH 5 (10%-ig vandig saltsyre) under omrøring. Den organiske fase fraskilles, og den vandige fase etterekstraheres enda en gang med 200 ml eddiksyreetylester. De kombinerte, organiske faser tørkes over magnesiumsulfat, løs-ningsmidlet destilleres av i vakuum, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/n-heksan/etanol = 20:8:2). De produktholdige fraksjoner inndampes. A mixture of 54.1 g (100 mmol) 2,3,4,6-tetra-O-benzyl-mannopyranose, 1.7 g (5 mmol) tetrabutylammonium hydrogen sulfate and 33.7 g (600 mmol) finely powdered potassium hydroxide in 350 ml benzene is cooled to 0 °C. At 0 °C, 31.4 g (150 mmol) of 2,2-dimethyl-propionic acid-2-bromomethyl ester are added dropwise over the course of 30 minutes with vigorous stirring. He stirs for 2 hours at 0 °C. 300 ml of benzene are added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The remainder is taken up in 500 ml ethanol/100 ml water. 100 ml of 50% aqueous lye is added and boiled for 8 hours under reflux. It is cooled to 0 °C, adjusted to pH 8 with 10% aqueous hydrochloric acid, and then the solvent is distilled off (vacuum). The residue is taken up in 300 ml of water, 400 ml of acetic acid ethyl ester and the pH value of the aqueous phase is adjusted to pH 5 (10% aqueous hydrochloric acid) while stirring. The organic phase is separated, and the aqueous phase is extracted once more with 200 ml of ethyl acetate. The combined organic phases are dried over magnesium sulphate, the solvent is distilled off in vacuo, and the residue is chromatographed on silica gel (eluent: dichloromethane/n-hexane/ethanol = 20:8:2). The product-containing fractions are evaporated.
Utbytte: Dividend:
45,6 g (78% av det teoretiske, over 2 trinn) av en fargeløs, 45.6 g (78% of the theoretical, over 2 steps) of a colorless,
seig olje. tough oil.
Elementæranalyse: Elemental analysis:
Eksempel 18 Example 18
2, 3, 4, 6- tetra- O- benzyl- 1- 0-( l- hydroksy- heks- 6- yl)- glukopyranose 2, 3, 4, 6- tetra- O- benzyl- 1- O-( l- hydroxy- hex- 6- yl)- glucopyranose
En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-0-benzyl-glukopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid og 24 g (600 ml) finpulverisert natriumhydroksid i 350 ml diklormetan avkjøles til 10 °C. Ved 10 °C tilsetter man 41,3 g (140 mmol) 1-(dimetyl-tert.-butylsilyloksy)-6-bromheksan oppløst i 100 ml diklormetan, dråpevis i løpet av 50 minutter under sterk omrøring. Man omrører i 3 timer ved 10 °C. Man tilsetter 350 ml diklormetan, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 350 ml acetonitril, og 52,3 g (200 ml) tetrabutylammoniumfluorid (som monohydrat) tilsettes. Man omrører i 3 timer ved 50 °C. Oppløs-ningen blir konsentrert til tørrhet og resten kromatografert på silikagel (elueringsmiddel: diklormetan/etanol = 20:1). Utbytte: 49,3 g (77% av det teoretiske, over 2 trinn) av et fargeløst, fast stoff. A mixture of 54.1 g (100 mmol) of 2,3,4,6-tetra-0-benzyl-glucopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride and 24 g (600 ml) of finely powdered sodium hydroxide in 350 ml of dichloromethane is cooled to 10 °C. At 10 °C, 41.3 g (140 mmol) of 1-(dimethyl-tert-butylsilyloxy)-6-bromohexane dissolved in 100 ml of dichloromethane are added dropwise over 50 minutes with vigorous stirring. The mixture is stirred for 3 hours at 10 °C. 350 ml of dichloromethane is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The residue is taken up in 350 ml of acetonitrile, and 52.3 g (200 ml) of tetrabutylammonium fluoride (as monohydrate) is added. The mixture is stirred for 3 hours at 50 °C. The solution is concentrated to dryness and the residue chromatographed on silica gel (eluent: dichloromethane/ethanol = 20:1). Yield: 49.3 g (77% of theory, over 2 steps) of a colorless solid.
Elementæranalyse: Elemental analysis:
Eksempel 19 Example 19
2, 3, 4, 6- tetra- O- benzyl- l- O-( l- hydroksy- et- 2- yl)- galaktopyranose 2, 3, 4, 6- tetra- O- benzyl- l- O-( l- hydroxy- et- 2- yl)- galactopyranose
En blanding av 54,1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -benzylgal akt opyranose, 1,64 g (15 mmol) tetrametylammoniumklorid i 350 ml toluen og 200 ml 60%-ig vandig natronlut avkjøles til 0 °C. Ved 0 °C tilsetter man 52,7 g (130 mmol) 2-(4,4'-dimetoksytrifenylmetyloksy)-etylbromid oppløst i 100 ml toluen, dråpevis i løpet av 30 minutter under sterk omrøring. Man omrører i 3 timer ved 0 °C. Man tilsetter 300 ml toluen, fraskiller den organiske fase og ekstraherer den vandige fase 2 ganger med 200 ml toluen. Løsningsmidlet destilleres av i vakuum. Resten tas opp i 500 ml diklormetan, og 25 g (194 mmol) dikloreddiksyre tilsettes. Man omrører i 3 timer ved 35 "C. Oppløsningen vaskes 3 ganger med 300 ml 10%-ig vandig natronlut, og den organiske fase konsentreres til tørrhet og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/etanol 20:1). A mixture of 54.1 g (100 mmol) 2,3,4,6-tetra-O-benzyl -benzylgalact opyranose, 1.64 g (15 mmol) tetramethylammonium chloride in 350 ml toluene and 200 ml 60% aq. lye is cooled to 0 °C. At 0 °C, 52.7 g (130 mmol) of 2-(4,4'-dimethoxytriphenylmethyloxy)-ethyl bromide dissolved in 100 ml of toluene are added dropwise over the course of 30 minutes with vigorous stirring. The mixture is stirred for 3 hours at 0 °C. 300 ml of toluene is added, the organic phase is separated and the aqueous phase is extracted twice with 200 ml of toluene. The solvent is distilled off in a vacuum. The residue is taken up in 500 ml of dichloromethane, and 25 g (194 mmol) of dichloroacetic acid are added. The mixture is stirred for 3 hours at 35 °C. The solution is washed 3 times with 300 ml of 10% aqueous sodium hydroxide solution, and the organic phase is concentrated to dryness and the residue is chromatographed on silica gel (eluent: dichloromethane/ethanol 20:1).
Utbytte: Dividend:
46,29(79% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. 46.29 (79% of theoretical, over 2 steps) of a colorless, viscous oil.
Elementæranalyse: Elemental analysis:
Eksempel 20 Example 20
2, 3, 4- tri- 0- benzyl- 6- desoksy- l- 0-( l- hydroksy- 3, 6, 9, 12- tetraaza-tetradek- 14- yl)- galaktopyranose 2, 3, 4- tri- 0- benzyl- 6- deoxy- 1- 0-( 1- hydroxy- 3, 6, 9, 12- tetraaza- tetradec- 14- yl)- galactopyranose
En blanding av 43,5 g (100 mmol) 2,3,4-tri-0-benzyl-6-desoksygalaktopyranose, 1,39 g (5 mmol) tetrabutylammoniumklorid og 24 g (600 mmol) finpulverisert natriumhydroksid i 350 ml tetrahydrofuran avkjøles til 0 °C. Ved 0 °C tilsetter man 66,1 g (130 mmol) 14-tosyloksy-3,6,9,12-tetraaza-l-(dimetyl-tert.-butylsilyloksy)-tetradekan, oppløst i 100 ml tetrahydrofuran, dråpevis i løpet av 4 0 minutter under sterk omrøring. Man omrører i 3 timer ved 10 °C. Man tilsetter 300 ml diklormetan, filtrerer av fra det faste stoff og inndamper filtratet til tørrhet i vakuum. Resten tas opp i 350 ml acetonitril, og 52,3 g (200 ml) tetrabutylammoniumfluorid tilsettes som monohydrat. Man omrører i 3 timer ved 50 °C. Oppløsningen konsentreres til tørr-het, og resten kromatograferes på silikagel (elueringsmiddel: diklormetan/etanol = 20:1). A mixture of 43.5 g (100 mmol) of 2,3,4-tri-0-benzyl-6-deoxygalactopyranose, 1.39 g (5 mmol) of tetrabutylammonium chloride and 24 g (600 mmol) of finely powdered sodium hydroxide in 350 ml of tetrahydrofuran is cooled to 0 °C. At 0 °C, 66.1 g (130 mmol) of 14-tosyloxy-3,6,9,12-tetraaza-1-(dimethyl-tert-butylsilyloxy)-tetradecane, dissolved in 100 ml of tetrahydrofuran, are added dropwise in the course of 40 minutes under vigorous stirring. The mixture is stirred for 3 hours at 10 °C. 300 ml of dichloromethane is added, the solid is filtered off and the filtrate is evaporated to dryness in a vacuum. The residue is taken up in 350 ml of acetonitrile, and 52.3 g (200 ml) of tetrabutylammonium fluoride is added as monohydrate. The mixture is stirred for 3 hours at 50 °C. The solution is concentrated to dryness, and the residue is chromatographed on silica gel (eluent: dichloromethane/ethanol = 20:1).
Utbytte: Dividend:
51,1 g (78% av det teoretiske, over 2 trinn) av en fargeløs, seig olje. 51.1 g (78% of theory, over 2 steps) of a colorless, viscous oil.
Elementæranalyse: Elemental analysis:
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10013328A DE10013328C2 (en) | 2000-03-10 | 2000-03-10 | Process for the preparation of perbenzylated 1-O-glycosides |
PCT/EP2001/002024 WO2001068659A2 (en) | 2000-03-10 | 2001-02-22 | Method for the production of perbenzylated 1-o glycosides |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20024290L NO20024290L (en) | 2002-09-09 |
NO20024290D0 NO20024290D0 (en) | 2002-09-09 |
NO323684B1 true NO323684B1 (en) | 2007-06-25 |
Family
ID=7635315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024290A NO323684B1 (en) | 2000-03-10 | 2002-09-09 | Process for Preparation of Perbenzylated 1-O-Glycosides |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1261614B1 (en) |
JP (1) | JP2003527397A (en) |
AT (1) | ATE257483T1 (en) |
AU (1) | AU2001254659A1 (en) |
DE (2) | DE10013328C2 (en) |
DK (1) | DK1261614T3 (en) |
ES (1) | ES2213692T3 (en) |
NO (1) | NO323684B1 (en) |
WO (1) | WO2001068659A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6545135B2 (en) * | 2000-03-10 | 2003-04-08 | Schering Aktiengesellschaft | Process for the production of perbenzylated 1-O-glycosides |
DE10129677C2 (en) * | 2001-06-18 | 2003-10-16 | Schering Ag | Process for the preparation of perbenzylated 1-O-glycosides |
DE10129888C2 (en) * | 2001-06-19 | 2003-10-16 | Schering Ag | Process for the preparation of perbenzylated 1-O-glycosides |
US6831164B2 (en) | 2001-07-11 | 2004-12-14 | Schering Aktiengesellschaft | Process for the production of peracylated 1-0-glycosides |
DE10135098B4 (en) * | 2001-07-11 | 2004-05-13 | Schering Ag | Process for the preparation of peracylated 1-O-glycosides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1122897A (en) * | 1995-11-13 | 1997-06-05 | Glycomed Incorporated | Novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties |
JP3816570B2 (en) * | 1996-02-16 | 2006-08-30 | 塩水港精糖株式会社 | Acylating agent |
-
2000
- 2000-03-10 DE DE10013328A patent/DE10013328C2/en not_active Expired - Fee Related
-
2001
- 2001-02-22 AT AT01927688T patent/ATE257483T1/en not_active IP Right Cessation
- 2001-02-22 DE DE50101293T patent/DE50101293D1/en not_active Expired - Fee Related
- 2001-02-22 DK DK01927688T patent/DK1261614T3/en active
- 2001-02-22 EP EP01927688A patent/EP1261614B1/en not_active Expired - Lifetime
- 2001-02-22 AU AU2001254659A patent/AU2001254659A1/en not_active Abandoned
- 2001-02-22 WO PCT/EP2001/002024 patent/WO2001068659A2/en active IP Right Grant
- 2001-02-22 ES ES01927688T patent/ES2213692T3/en not_active Expired - Lifetime
- 2001-02-22 JP JP2001567749A patent/JP2003527397A/en not_active Withdrawn
-
2002
- 2002-09-09 NO NO20024290A patent/NO323684B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK1261614T3 (en) | 2004-04-26 |
AU2001254659A1 (en) | 2001-09-24 |
DE10013328A1 (en) | 2001-09-20 |
JP2003527397A (en) | 2003-09-16 |
EP1261614A2 (en) | 2002-12-04 |
WO2001068659A2 (en) | 2001-09-20 |
NO20024290L (en) | 2002-09-09 |
ATE257483T1 (en) | 2004-01-15 |
NO20024290D0 (en) | 2002-09-09 |
DE10013328C2 (en) | 2002-12-19 |
EP1261614B1 (en) | 2004-01-07 |
DE50101293D1 (en) | 2004-02-12 |
ES2213692T3 (en) | 2004-09-01 |
WO2001068659A3 (en) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050124563A1 (en) | Triazole linked carbohydrates | |
SI9620099A (en) | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a | |
US6573337B1 (en) | Oligosaccharide synthesis | |
NO323684B1 (en) | Process for Preparation of Perbenzylated 1-O-Glycosides | |
Liautard et al. | Novel Galf-disaccharide mimics: synthesis by way of 1, 3-dipolar cycloaddition reactions in water | |
Ogawa et al. | Synthesis of an ether-linked alkyl 5a-carba-β-d-glucoside, a 5a-carba-β-d-galactoside, a 2-acetamido-2-deoxy-5a-carba-β-d-glucoside, and an alkyl 5a′-carba-β-lactoside | |
US6545135B2 (en) | Process for the production of perbenzylated 1-O-glycosides | |
EP1017683A1 (en) | Protecting and linking groups for organic synthesis | |
Huang et al. | Synthesis of (R)-2, 3-epoxypropyl (1→ 3)-β-d-pentaglucoside | |
US6908989B2 (en) | Process for the production of perbenzylated 1-O-glycosides | |
US6831164B2 (en) | Process for the production of peracylated 1-0-glycosides | |
Waard | Attempts at the synthesis of a novel sialic acid ABPP probe for viral neuraminidases | |
DE10135098B4 (en) | Process for the preparation of peracylated 1-O-glycosides | |
DE10129677C2 (en) | Process for the preparation of perbenzylated 1-O-glycosides | |
AU756536B2 (en) | Protecting and linking groups for organic synthesis | |
Deeble | The efficient synthesis of 1-deoxymannojirimycin and its derivatives | |
AU3842297A (en) | Oligosaccharide synthesis | |
JPH0154357B2 (en) | ||
JPS6330918B2 (en) |